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Abstract 
Homeostasis of the central nervous system (CNS) is critically dependent on cerebrospinal and 
interstitial fluid dynamics and therewith associated transport processes. While our understanding of 
these processes relies heavily on in vivo tracer experiments and cerebrospinal fluid (CSF) protein 
analysis, interpretation of the corresponding data is far from trivial, challenged by the number of 
transport pathways and unknown underlying transport mechanisms. In the framework of this thesis, 
we have developed as well as applied computational techniques to shed light on the physiological 
mechanisms underlying the observed solute distributions, and to advance our understanding of CNS 
solutes dynamics. In vivo observations of rapid tracer transport along the cerebral paravascular 
spaces (PVS) have led to the hypothesis of a fast clearance system driven by bulk flow. We 
demonstrate that this so‐called glymphatic system would require substantial intracellular water flux 
through a network of astrocytes maintained by a thus far unknown driving force. We further show 
that arterial pulsations alone are not sufficient to generate this force. However, even in the absence 
of a net force and directed bulk flow, pulsations of the arterial wall and thereby generated periodic 
fluid motion still enhance transport in the PVS via dispersion. Such a mechanism may reconcile 
various tracer studies that have thus far been considered contradictory. Finally, we show that 
pathological alterations in CSF protein content may be related both to alterations of the blood‐CSF 
barrier and CSF dynamics, with potential implications for the treatment of neurological disorders. 
  
ii 
 
Zusammenfassung 
Die Homöostase des zentralen Nervensystems ist eng mit der Strömungsdynamik von Liquor (engl.: 
cerebrospinal fluid, CSF) und interstitieller Flüssigkeit und den damit verbundenen 
Transportprozessen verknüpft. Während das aktuelle Verständnis dieser Prozesse auf in vivo Tracer‐
Experimenten und Proteinanalysen des Liquors beruht, ist die Interpretation der experimentellen 
Daten aufgrund der vielen möglichen Transportwege und den zugrundeliegenden, teilweise noch 
unbekannten Transportmechanismen  nicht trivial. Im Rahmen dieser Doktorarbeit haben wir 
rechnergestützte Methoden entwickelt, welche jene physiologischen Prozesse beschreiben, die der 
beobachteten Konzentrationsverteilung von gelösten Stoffen im CSF zu Grunde liegen, um dadurch 
schliesslich das Verständnis für die Stofftransporte im Gehirn zu verbessern. Die in vivo Beobachtung 
von schnellem Transport von Tracern innerhalb des zerebralen paravaskulären Raums (engl.: 
paravascular space, PVS) bildet die Grundlage der Hypothese, dass ein strömungsabhängiges 
zerebrales Reinigungssystem existiert. Wir veranschaulichen, dass dieses sogenannte glymphatische 
System einen beträchtlichen intrazellulären Fluss durch ein Netzwerk von Astrozyten erfordert, das 
von einem bis anhin unbekannten Mechanismus angetrieben wird. Wir zeigen weiter, dass die 
arterielle Pulsation allein nicht ausreicht, um diesen geforderten Antrieb zu erzeugen. Dennoch 
können das Pulsieren der Arterienwände und das dadurch induzierte periodische Strömungsfeld den 
Stofftransport im PVS verstärken, und zwar mittels Dispersion. Ein solcher Mechanismus wäre dazu 
imstande, verschiedene Tracer‐Studien, die bis anhin als widersprüchlich galten, miteinander in 
Einklang zu bringen. Schliesslich zeigen wir, dass pathologische Veränderungen im Proteingehalt des 
CSFs möglicherweise auf Veränderungen der Blut‐CSF‐Schranke oder der CSF Dynamik 
zurückzuführen sind, was Implikationen auf die Behandlung neurologischer Störungen hätte. 
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Chapter 1 Introduction 
Cerebrospinal fluid is the second large liquid compartment of the brain after blood. This liquid flows 
in the core of the brain in the ventricular system from where it connects to cranial and spinal 
subarachnoid spaces (SAS) and surrounds the whole central nervous system as shown in the 
schematic of Figure 1.1. Investigation of cerebrospinal fluid (CSF) physiology has attracted scientists 
for a long time since it is thought to be very essential for the normal functioning of the central 
nervous system. While CSF is considered crucial for mechanical protection of the brain and spine 
from incidents, it is also seen very important for chemical balance of the organ.  
    Traditional model of the cerebrospinal fluid physiology 
The classical model of the CSF physiology pictures a continuous CSF pathway originating in the 
ventricular system, flowing through the cisternal space into subarachnoid spaces. This classical flow 
pathway is demonstrated with the arrows in Figure 1.1. In this view, CSF would be produced mainly 
by the choroid plexus layer in the ventricles. This assumption was supported by the animal studies of 
Dandy [1] in which removal of the choroid plexus layer from one of the lateral ventricles in a dog 
brain lead to the collapse of that ventricle while the other ventricle started dilating. In the 
subarachnoid space, CSF would ultimately be reabsorbed into the venous system through the 
arachnoid granulations [2]. The anatomical structure of these granulations resemble the pressure 
sensitive one way valves which allow for the bulk transcellular drainage of the liquid [3]. 
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Figure 1.1: The schematic of the CSF compartments in the central nervous system and their 
connectivity. The classical flow pathway described for the CSF is shown with the black arrows starting 
from the choroid plexus layer as the major production site and ending to arachnoid granulations as 
the major absorption site. 
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    New understanding of the CSF physiology 
While the classical model of a directed circulation from lateral ventricles to subarachnoid space has 
been assumed even by some recent reviews [4], there are pool of evidences that this directed flow of 
CSF is only a rough simplification of a much more complicated flow system. Dandy’s experiments 
have been also criticized because of intrinsic large possible errors in the experimental procedure 
since several preparations required considerable operative manipulations [5, 6].  Some experimental 
studies including radioactive water studies indicated that at least some of the CSF originates from 
another source than the choroid plexus. This secondary source of CSF could be the ependymal 
surface or the blood brain barrier of the capillary network within the brain tissue [7]. The interstitial 
liquid secreted by capillaries might drain to the pool of CSF [8] and increase the net CSF production 
rate. The rate of interstitial liquid clearance has been estimated by measuring the rate of the tracers 
removal from the tissue after tracers injection [9]. 
The drainage pathways for the cerebrospinal fluid are vast and do not restrict to the arachnoid 
granulations. It is shown that considerable amount of CSF might drain along perineural spaces to the 
cervical lymphatics [10]. Dural lymphatic vessels have been recently discovered adjacent to the 
cortical subarachnoid space [11]. The finding of these lymphatic vessels might solve the old puzzle of 
whether brain is an immune privilege organ or not. Antigens available in the cerebrospinal fluid could 
stimulate immune reactions by draining through these dural lymphatic vessels. 
The circulation of the cerebrospinal fluid has been also extensively revisited. Advances in magnetic 
resonance flow studies made it possible to measure the CSF flow velocities in the ventricular system 
[12]. These measurements revealed that on top of the directed CSF flow in the ventricular system, 
there are relatively large amplitude flow pulsations [13]. Next to these macro‐scale complexities in 
the CSF dynamics, high resolution imaging techniques have revealed that CSF transport might also 
occur in micro‐circulations. Cilia beating could induce complex micro‐flows in vicinity of the ventricles 
walls  [14]. It has been shown that network of paravascular spaces surrounding the penetrating 
arteries provides micro‐pathways connecting the interstitial liquid in the extracellular spaces to the 
surrounding CSF pool [15]. This complex network serves as the secondary circulation pathway for the 
cerebrospinal fluid in the brain. Since this circulation connects the cellular environment of the brain 
to the peripheral lymphatic system, it is called as glymphatic system. We will discuss this system in 
more details in the following section. 
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    Cerebrospinal fluid circulation in the paravascular spaces network 
Zhang et al. [16] showed that subarachnoid space extends to the cerebral cortex along the 
penetrating vessels branching from the larger surficial vessels in the SAS. This anatomical extension 
of SAS was called paravascular space (PVS) [15], also perivascular space [16] and Virchow robin space 
[16]. This space surrounding the arteries and arterioles was shown to be covered with a thin sheath 
of pia mater. Therefore, the borders of the PVS are restricted innerly by the outermost layer of the 
blood vessel wall (adventitia) and outerly by the thin sheath of pia layer wrapped with the glial 
endfeet layer. Similar paravascular spaces were also found in other human brain regions such as 
basal ganglia [17]. Regional differences were observed in the structure of the covering 
leptomeningeal layers. Two leptomeningeal layers cover the paravascular spaces in the basal ganglia 
while there is only one in the cerebral cortex region. Since discovery of PVS, these cerebral channels 
attracted lots of attention as they serve as transport pathways for CSF and its solutes content 
between brain interstitial space and subarachnoid space. The direction of this transport and its rate, 
however, has been debated among the investigators [18‐20].   
Recently, Iliff et al. [15] revived this long‐standing discussion about transport mechanisms in the 
paravascular spaces with their tracer studies after cisternal solutes injection. They showed the rapid 
movement of the large tracers from subarachnoid space into the parenchyma along periarterial 
pathway and eventually drainage of these solutes along perivenous pathway. This potential 
circulation of the cerebrospinal fluid and its solutes content in PVS network could come along the 
recent discovery of the dural lymphatic drainage of the cerebrospinal fluid to build the immune 
reaction system of the brain. Due to this potential connection to lymphatic function of the brain, this 
circulation system is called “glymphatic system”. However, since the state of the art imaging 
techniques could not resolve the single molecules transport in the brain tissue, the real transport 
mechanisms functioning in this pathway are still unclear. This has even led to contradicting 
interpretations about the solutes transport direction in the PVS obtained by similar set of 
experiments. Arbel‐Ornath et al. has shown that intraparenchymal injection of the tracers leads to 
rapid transport of these molecules along the periarterial space from parenchyma towards 
subarachnoid space [21] which is in the reverse direction of what Iliff et al. [15] showed. This 
motivates us to use our computational modeling tools developed based on the biophysical principles 
in order to clarify the transport mechanisms for the CSF and its solutes content in this network. 
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    Cellular and molecular mechanisms 
Aquaporins (AQP) are specific water channels expressed on the cellular membranes which facilitate 
water transport through the hydrophobic cell membrane [22]. In the central nervous system, AQP4 is 
highly expressed on the astrocytes membranes. The expression of these channels is highly localized 
on the endfeet processes of the astrocytes which wrap the outer surface of the PVS [23]. This 
localized expression of AQP4 water channels adjacent to the paravascular spaces points towards a 
potential important role of these channels in cerebral water transport [22]. Astrocytes are shown to 
be involved in several regulatory mechanisms which are essential for maintaining the central nervous 
system homeostasis [24]. Due to their connections including the endfeet processes covering the 
blood capillaries and their synaptic connections with neurons, they are nominated as a key 
messenger and regulator in the neurovascular unit [25]. 
Iliff et al. demonstrated that AQP4 knocked out animals inhibit the fast transport of the tracers 
through the glymphatic system of the brain [15]. However, it is not trivial to explain why aquaporin 
water channels removal could lead to less solute transport in the brain. These channels are directly 
involved in water transport, but cannot transport large molecules such as tracers. Tracers could only 
move along the gaps between the astrocytes endfeet processes. Therefore in chapter 2 of this thesis, 
we try to answer the question of how AQP4 water channels and astrocytes could contribute to 
solutes transport in the brain. 
    The possibility of CSF bulk flow in paravascular spaces and its driving force 
The idea of bulk CSF flow in paravascular spaces in the brain raised from the observation of rapid 
transport of injected tracers along this network [9, 20]. This rapid solute transport was assumed to 
result from directional advective transport induced by bulk flow of CSF in that space. However, the 
direction of this bulk flow was not concluded due to contradictory observations from tracer studies. 
While injection in the subarachnoid space led to fast transport of the tracers in the paravascular 
spaces towards the parenchyma [20], intraparenchymal injection resulted in a reverse transport 
towards the subarachnoid space [21]. This confusion was reinforced since the driving force for the 
CSF bulk flow in both directions was introduced as the arterial blood pulsations. Ligation of the main 
cerebral arteries led to dampening of the arterial pulsation and consequently inhibited the rapid 
transport of the tracers [20]. Several experimental and theoretical studies have been conducted to 
justify the bidirectional bulk flow of CSF in the paravascular spaces [26‐28]. In chapter 3 of this thesis, 
we demonstrate that, under physiological conditions, arterial pulsations are unlikely to generate 
substantial bulk flow and advective transport, but may still be contribute to enhanced solute 
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transport by dispersion. This hypothesis could explain the bidirectional rapid solute transport and 
therefore solve the intrinsic conflict with the CSF bulk flow assumption.  
    CSF dynamics role in distribution of the natural solutes such as proteins 
The role of CSF dynamics in macro‐scale solutes transport in the central nervous system is already 
shown [29, 30]. However, its influence on the CNS natural protein levels and distribution is missing. 
Since albumin protein is purely blood derived, its level in cerebrospinal fluid is seen as a reference 
value to characterize the central nervous system barriers permeability to proteins. Abnormal 
variation of albumin and immunoglobulin antibodies concentration in CSF is considered as hallmark 
of neurological diseases [31]. While the pathophysiological origins of CSF protein levels variation are 
still debated, both change in CSF drainage and dynamics in the cranio‐spinal space [32, 33] as well as 
dysfunction of the blood‐CNS barrier [31] have been suggested as possible causes of increased 
concentration of blood‐derived proteins. In chapter 4, we show that both barrier dysfunction and CSF 
drainage change could lead to CSF protein levels variation, but this is only barrier dysfunction which 
could explain the characteristic behaviours observed for the protein variation in the experimentally 
derived CSF quotient diagrams. 
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Chapter 2 How astrocyte networks may contribute to cerebral metabolite 
clearance  
This chapter has been published as: 
Asgari, Mahdi, Diane de Zélicourt, and Vartan Kurtcuoglu. "How astrocyte networks may 
contribute to cerebral metabolite clearance." Scientific reports 5 (2015). 
     Abstract 
The brain possesses an intricate network of interconnected fluid pathways that are vital to the 
maintenance of its homeostasis. With diffusion being the main mode of solute transport in cerebral 
tissue, it is not clear how bulk flow through these pathways is involved in the removal of metabolites. 
In this computational study, we show that networks of astrocytes may contribute to the passage of 
solutes between tissue and paravascular spaces (PVS) by serving as low resistance pathways to bulk 
water flow. The astrocyte networks are connected through aquaporin‐4 (AQP4) water channels with 
a parallel, extracellular route carrying metabolites. Inhibition of the intracellular route by deletion of 
AQP4 causes a reduction of bulk flow between tissue and PVS, leading to reduced metabolite 
clearance into the venous PVS or, as observed in animal studies, a reduction of tracer influx from 
arterial PVS into the brain tissue. 
 
Key words: Cerebral fluid flow, Aquaporin‐4, Paravascular space, Astrocyte network, Extracellular 
flow, Computational model  
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    Introduction  
Homeostasis of the central nervous system is critically dependent on cerebrospinal and interstitial 
fluid flows and therewith associated transport processes. While it is possible to measure 
cerebrospinal fluid (CSF) flow in vivo at some locations [34], flow of the interstitial fluid (ISF) cannot 
be acquired directly, but only be inferred from the evolution of tracer distribution patterns [9, 18, 
21]. However, tracers can spread in absence of flow simply driven by diffusion [35], and they can also 
spread in the absence of both diffusion and net flow by local advective mixing [30]. Consequently, a 
given tracer distribution in the brain could be the result of one of several possible flow fields. The 
interpretation of tracer studies with respect to the underlying flow field is thus anything but trivial. 
Recent in vivo two‐photon excitation microscopy studies in mice have addressed the role of 
aquaporin‐4 (AQP4) water channels on the transport of fluorescent tracers in the brain [15]. In mice 
lacking AQP4, the time for tracers injected into the CSF to reach the ISF through paravascular spaces 
(PVS) was increased, which was interpreted as a consequence of reduced CSF influx into the PVS. 
While this interpretation appears intuitive at first, it becomes much less evident on second thought: 
Both fluid and tracers pass from the PVS to the ISF via gaps between astrocyte endfeet, but only fluid 
leaves the PVS additionally through AQP4. If this second pathway is removed, there should not be 
reduced fluid passage through the first and the time for tracers to reach the ISF should not increase.  
Light may be shed onto this challenging constellation if one considers that AQP4 does not connect 
the PVS directly to the ISF, but rather connects it to the intracellular space of astrocytes through their 
endfeet first [23]. The intracellular space then communicates with the ISF via AQP4 expressed on the 
entire plasma membrane. Since astrocytes can exchange water both through the surrounding ISF and 
directly through gap junction connections with neighbouring astrocytes, fluid originating in the 
arterial PVS may flow through a network of astrocytes before reaching the venous PVS [24, 36]. As 
tracers will not pass through AQP4, and tracking of labelled water cannot be achieved in vivo with 
sufficiently high resolution, a computational approach to the analysis of water flow between 
paravascular spaces is warranted. Computational methods for the study of cerebral fluid dynamics 
have made great strides in recent years, and have become valuable tools that can complement 
experimental approaches [37‐40]. 
Herein we aim to elucidate through numerical experiments the changes in fluid flow that lead to 
altered tracer distribution patterns upon AQP4 deletion observed in vivo. The underlying 
mathematical model considers both intra‐ and extracellular water pathways in a network of 
astrocytes between two neighbouring arterial and venous PVS. Based on the calculated fluid flow, we 
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further comment on the relative contributions of advection and diffusion on solute transport in the 
extracellular and paravascular spaces.  
    Methods 
The model represents the space between a penetrating cortical arteriole and its venous counterpart 
in a mouse brain as shown in Figure 2.1. The vessels are spaced 300 µm apart [24]. In vivo, astrocytes 
form a structured network between adjacent larger blood vessels [25]. Each astrocyte can be thought 
of possessing its own domain with nominal diameter of 50 µm [24]. We refer to this domain as 
astrocyte unit (AU). An AU contains one astrocyte, parts of other cerebral cell types such as neurons, 
oligodendrocytes and microglia, as well as extracellular space at an overall ratio of 1:4 between 
extra‐ and intracellular spaces. Each AU is associated with one capillary blood vessel (see 
Supplementary Information S1). 
There are nominally six AUs between arteriole‐venule pairs, where one AU is in direct contact with 
the arterial and one with the venous PVS. These two units are referred to as perivascular AUs, while 
the remaining four constitute the central astrocyte units. All AUs are in contact with the basement 
membrane (BM) of their own associated capillary [41]. Capillary basement membranes of 
neighbouring AUs are in direct contact, representing the connectivity of the capillary bed. The 
capillary basement membranes of the two perivascular AUs connect additionally to their respective 
adjacent PVS. 
Astrocyte endfeet establish the contact between AU and PVS, as well as between AU and capillary 
basement membrane [42], and thereby define two parallel fluid pathways: One through AQP4 
expressed on the endfoot plasma membrane, and one through gaps between adjacent endfeet. Such 
inter‐endfeet gaps (IEG) also allow the passage of solutes with hydrodynamic diameter of up to 20 
nm [15, 42], whereas AQP4 only carries water. In the central part of the network, intra‐ and 
extracellular spaces and capillary basement membranes act as parallel fluid pathways that are in a 
constant exchange of water through AQP4 expressed on the astrocyte plasma membrane. The 
intracellular spaces of neighbouring astrocytes can further communicate directly through gap 
junction proteins, which are fairly large channels with hydrodynamic diameter of 2.5‐4.5 nm [43] that 
allow for passage of molecules with molecular mass less than 1000 Da [24].  
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Figure 2.1: Sketch of the model domain consisting of an astrocyte network between arterial and 
venous paravascular spaces (PVS). The network consists of several astrocyte units (AU) that each 
include one astrocyte (Ast) expressing aquaporin‐4 (AQP4) water channels, extracellular space (ECS) 
and parts of the intracellular space of other cells including neurons, oligodendrocytes and microglia. 
Note that the schematic is not drawn to scale and does not represent the true ratio between intra‐ 
and extracellular space. The perivascular AUs are in direct contact with their neighbouring PVS via 
the respective astrocyte’s endfoot (EF). All astrocytes connect via endfeet to the basement 
membrane (BM) of the capillary associated with their AU. Neighbouring BMs connect to each other, 
and the perivascular BMs are additionally connected to the corresponding PVS (indicated by arrows 
in the figure). AQP4 covering each of these endfeet connect the capillary BMs or the PVS to the 
intra‐astrocyte space. The intra‐astrocyte and extracellular spaces within a given AU are in constant 
exchange of water through AQP4 water channels expressed in the astrocyte plasma membrane 
(PM). Gap junctions (GJ) connect the intracellular spaces of two adjacent astrocytes. PR: Astrocyte 
process. IEG: Inter‐endfeet‐gap. 
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In vivo tracer studies suggest the existence of net flow from the arterial to venous PVS, and therefore 
of a driving force gradient between the two spaces [15]. Neither origin nor magnitude of this 
purported gradient is known: next to arterial wall pulsations that are hypothesized to produce a 
driving hydrostatic pressure gradient, other driving forces are plausible as well. To reproduce the net 
effect of several possible forces and to employ a reasonable gradient magnitude, we set a pressure 
difference between arterial and venous PVS that yields a baseline extracellular fluid flow velocity in 
line with experimentally estimated values in grey matter [44]. As we will discuss in Supplementary 
Information S3, variation of the gradient magnitude within a reasonable range does not affect the 
conclusions of our investigation. 
The computational implementation of the model is based on electrical analogy to fluid flow: 
pressure, resistance to flow and flow rate are represented by electric potential, resistance and 
current, respectively. Figure 2.2 shows the corresponding electrical network. The overall pressure 
drop is set to where under nominal conditions ISF flow velocity reaches 1	
  
   
, corresponding to 
experimental estimates in the grey matter [44]. A sensitivity analysis reported in Supplementary 
Information S3 shows that changing the nominal ISF flow velocity within the range of values reported 
in the literature [45] does not affect the conclusions drawn in this study. 
The distribution of flow between pathways depends on the resistances along those pathways. These 
include a) the resistances within the intra‐ and extracellular spaces and capillary basement 
membranes determined by their respective characteristic dimensions and properties; b) the 
interfacial resistances between astrocyte intracellular space and ECS, PVS or BM, divided between 
endfoot and the remainder of the plasma membrane; and c) the interfacial resistance between 
neighbouring astrocytes determined by the gap junction resistance to water passage. Values of the 
resistances and the driving pressure gradient are shown in Table 2.1 along with their derivation in 
concise form. Details are given in Supplementary Information S1. The underlying experimental values 
are listed in Table 2.2. 
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Figure 2.2: Electrical analogue model of cerebral water transport between arterial and venous 
paravascular spaces (PVS). Definitions of the abbreviations referring to the physical model domain 
are given in Figure 2.1. The voltage source represents the driving pressure difference between 
arterial and venous paravascular spaces that are connected by resistances (R) representing the 
resistance to fluid flow of capillary basement membrane (BM) segments and astrocyte units (AU). 
Each astrocyte unit (AU) includes resistances of both intracellular (cell processes, PR) and 
extracellular (ECS) pathways which are linked by membrane resistances, namely those of the 
astrocyte endfoot membrane (EF) and the remainder of the astrocyte plasma membrane (PM). Since 
these membrane resistances are dependent on the AQP4 expression level, they are indicated as 
variable resistances (arrows). Gap junction (GJ) resistances connect the intracellular spaces of two 
neighbouring astrocytes. 
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Next to water inflow from the arterial PVS, there is also the possibility of water secretion from 
capillaries into the parenchyma [9]. Since the experimental evidence for such secretion is 
unsatisfactory and no reliable quantitative data on the corresponding flow rate exist [46], we exclude 
capillary water secretion in the main calculations, but investigate its possible effects with an 
expanded model shown in Supplementary Fig. S2 and described in detail in Supplementary 
Information S1. Briefly, water secretion from the capillaries into the AUs is enforced and the pressure 
gradient between arterial and venous PVS is reduced so that the nominal flow rate through the tissue 
(combination of influx from the arterial PVS and secretion by capillaries) is maintained. As in the main 
model, AQP4 deletion is taken into account through a sevenfold increase in the astrocyte membrane 
resistances and, in addition, through a 31% reduction in capillary secretion rate as observed in glial‐
conditional AQP4 knockout mice after systemic hypoosmotic stress [47]. This explicit reduction is 
necessary because the capillary water secretion rate rather than a driving pressure gradient is 
prescribed. As shown in the sensitivity analysis in Supplementary Information S3, variation of the 
capillary secretion rate reduction within reasonable bounds does not affect the conclusions drawn in 
this study as long as the arterial PVS is the main source of water flux into the parenchyma.  
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Table 2.1: Definitions and nominal values of parameters used in the model. Derivations are 
documented in Supplementary Information S1. 
Parameter Equation Nominal value 
Pressure gradient between  arterial 
and venous PVS 
∆     =     _     	    _        	 226	Pa 
Capillary basement membrane 
resistance for half the length of one 
AU 
    =
(
   
2 )	 
   	   	          
 
7.1 ∗ 10  		
  
   
  
 
ECS resistance for half the length of 
one AU 
     =
    , 	
     	
 
1.12 ∗ 10  	
  
   
  
 
IEG resistance for the thickness of an 
endfoot 
     =
12μ   
    
    
 
9.5 ∗ 10  	
  
   
  
 
Resistance of intracellular pathway in 
the astrocyte processes  for half the 
length of one AU 
    =
128     (
   
2 )
    
   
2.56 ∗ 10  	
  
   
  
 
Endfoot membrane resistance     =
6
7
1
    ∗       _   ∗       
 
6.43 ∗ 10  	
  
   
  
 
Resistance of the plasma membrane in 
half of the astrocyte unit 
    =
6
7
∙
2
    ∗       _   ∗       
 
3.2 ∗ 10  	
  
   
  
 
Gap junction resistance     =
   , 
    ∗    
 
1.35 ∗ 10  	
  
   
  
 
    _       Total flow resistance in the ISF space between arterial and venous PVS;     _          
Nominal Interstitial fluid flow rate;     ,  Resistance of a single ECS pathway for half the length of 
one AU;     Diameter of the astrocyte unit;            Average number of capillaries in one AU;     
hydraulic permeability of the capillary basement membrane ;     the cross section area of 
basement membrane;       Number of parallel ECS pathways in one AU; μ dynamic viscosity of ISF; 
     endfoot thickness;      endfoot length;       thickness of IEG;      Tortuosity of the astrocyte 
processes;      Diameter of astrocyte process;        Water conductivity of a single AQP4;	     and 
     Endfoot and plasma membrane surface areas, respectively;       _    and       _    AQP4 
densities over the endfoot and plasma membrane, respectively;     ,  Water resistance of single gap 
junction channel;     density of gap junction channels;     surface area of the contact region 
between neighbouring astrocytes.
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Table 2.2: Parameters used for the derivation of the model parameters in Table 2.1. The most 
prominent spatial dimensions are illustrated in the Supplementary Figure S1. Derivations are all 
documented in details in Supplementary Information S1. 
Parameter Equation and nominal value Ref 
Pressures gradient   
ISF baseline velocity in the brain grey matter     _         = 1
  
   
 [44] 
Range of reported ISF velocities      = 0 − 14.5
  
   
 [44, 45] 
Vascular dimensions   
Distance between arteriole‐venule pair     = 300	μm  [24] 
Capillary diameter            	= 	5	μm  [48] 
Capillary volume fraction in the brain            = 1%  [49] 
Cortical penetrating arteriole diameter            	= 	25	μm  [49] 
Astrocyte dimensions   
AU diameter     = 50	μm  [24] 
AU volume     =  
   
 
4
= 98125	μm    
Astrocyte soma diameter       = 10	μm  [24] 
Surface area of astrocyte soma       = 4   
     
2
 
 
= 314	     
PM  to soma surface ratio    /     = 100 [24] 
PM surface area 
    =    /     ∗      
= 31400	     
Astrocyte process diameter     	= 	0.5	μm  [50] 
Process intracellular space tortuosity assuming 
cylindrical structures 
    =
 
2
= 1.57  
AQP4   
Single AQP4 channel water conductivity        = 24 ∗ 10
   	   /s [51] 
AQP4 density on EF       _   = 1000	  
   [52] 
AQP4 density on PM (except EF)       _   = 100	  
   [53] 
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EF length (estimated from the fact that EF fully 
wraps around capillaries) 
    =             = 15.7	   [42] 
EF width      = 5	   [42] 
EF surface area      =     ∙     = 78	  
   
EF thickness     = 1	μm  [42] 
GJ   
Hydraulic diameter of a GJ channel     = 3.5	nm  [43] 
PM thickness           = 5	nm  [54] 
Resistance of single GJ channel to water flow 
   ,  =
128 (2         )
    
 
= 2.7 ∗ 10  	
  
   
  
						
  
GJ channel density in the contact region between 
neighbouring astrocytes 
    = 200	  
   [55] 
Surface area of the contact region between 
neighbouring astrocytes 
    = 1  
  [55] 
ECS   
ECS thickness      	= 	20	nm  [56] 
Inter‐endfeet gap thickness      	=      	= 	20	nm  [15, 57] 
ECS volume fraction      = 20%  [35] 
Width of ECS channel surrounding typical cellular 
features (processes) 
      =      = 1.57	μm   
ECS tortuosity assuming cylindrical structures      =
 
2
= 1.57  
Resistance of a single ECS pathway for half the 
length of one AU 
    ,  =
12        
    
      
					
= 3.5 ∗ 10  	
  
   
  
  
Volume of a single ECS pathway for the length of 
one AU 
    ,  =    	       
Total ECS volume in one AU     ,  = φ    ∗     = 19625	  
   
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Number of parallel ECS pathways in one AU      =
    , 
    , 
= 31.25  
PVS 
Length of PVS segment considered for a 
penetrating vessel 
     = 500	   [49] 
Thickness of PVS channel      = 1	   [19] 
Hydraulic permeability of PVS      = 2 ∗ 10
    	
  
  .  
 [28] 
Capillary BM 
BM thickness     = 100	   [58] 
Hydraulic permeability of BM     = 2.25 ∗ 10
    	
  
  .  
 [59] 
Volume of single capillary with the length of one 
AU 
          ,  =    
          
2
 
 
∗    
= 981.25	    
 
Number of capillaries in one AU            =
           ∗    
          , 
= 1  
Cross section area of BM layer     =  	          	    = 1.57	  
   
Diffusion   
Diffusion coefficient for natural solutes and 
tracers in the brain parenchyma  	 = 0.5	to	5	 ∗ 10
    	
  
 
 [35] 
Fluid properties 
Dynamic viscosity   = 1 ∗ 10
   	
  
 .      
Density   = 1000	
  
  
    
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   Results 
Baseline flow rates and flow distribution between intra- and extracellular routes 
To analyse the relative contributions of the intra‐ and extracellular fluid routes, we probed the model 
under baseline conditions with all pathways open and all resistances set to their nominal value as 
described in the Methods section. Water enters the brain tissue from the arterial PVS through gaps 
between astrocyte endfeet and through AQP4 expressed on astrocyte endfeet at a ratio of about 3:1. 
This is illustrated in Figure 2.3 astrocyte unit (AU) position 1. Once inside the tissue, there is 
continuous exchange of water between the intra‐ and extracellular spaces through AQP4 channels 
covering the astrocyte cell body and processes. With the ECS and capillary basement membrane 
having a higher resistance to fluid flow than the intracellular space, water moves preferentially 
through the latter at a ratio of 3:1 (see Figure 2.3, AU positions 2 to 5). Flow distribution at the exit 
into the venous PVS is similar to the one at entry from the arterial PVS (AU position 6). At these entry 
and exit positions, flow rate through the ECS is 2.94 ∗ 10        ⁄ 	, and reduces to	1 ∗ 10   	     ⁄  
deeper in the brain tissue, yielding a mean ECS flow rate of 1.64 ∗ 10   	
   
 
. In absence of the 
intracellular route, the flow rate through the ECS would reach a similar value of 1.68	 ∗ 10        ⁄  
at all probed positions, but this would correspond to the overall flow rate from arterial to venous PVS 
(Figure 2.3, dashed horizontal line) through the parenchyma and would be less than half of the total 
water flow rate achieved with the astrocytes present (intra‐ and extracellular flows combined, 
4.16 ∗ 10        ⁄ ). 
Dependence of flow rate on number of astrocytes between arterial and venous PVS 
To quantify the contribution of the central astrocytes on fluid flow, we gradually reduced the number 
of astrocytes between adjacent PVS from six (baseline) to two (only perivascular astrocytes). The 
resulting gaps were filled with generic cells that do not express AQP4. Since in the central nervous 
system AQP4 channels were shown to be predominantly expressed in astrocytes [60, 61], these 
generic cells can be neurons, oligodendrocytes, microglia or any cells of the central nervous system 
other than astrocytes. As illustrated in Figure 2.4, lowering the number of central astrocytes leads to 
reduced flow between paravascular spaces, affecting water entry from the arterial PVS through IEG 
more than it affects entry through endfeet.   
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Figure 2.3: Flow rate distribution between intracellular, extracellular and capillary basement 
membrane pathways under normal conditions. AU Positions 1 and 6 refer the arterial and venous 
perivascular astrocyte units, respectively. The remaining positions refer to the central AUs. The 
dashed line indicates hypothetical extracellular flow rate (not including flow through basement 
membrane) in absence of the parallel, interconnected intracellular pathway. 
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Figure 2.4: Water flow rate from arterial PVS into the parenchyma as a function of the number of 
astrocytes between adjacent PVS. 6 astrocytes in this space correspond to the baseline, whereas the 
lowest shown number of 2 only includes the perivascular astrocytes. In configurations with less than 
6 astrocytes, the resulting gaps are assumed to be filled with generic cells that do not express AQP4. 
 
Dependence of flow rate on AQP4 expression 
To analyse the dependence of flow on AQP4, we disabled flow through these water channels, 
thereby replicating the experimental situation found in the in vivo tracer distribution study in AQP4 
knock‐out mice by Iliff and colleagues [15]. Deletion of AQP4 does not render the astrocyte 
membrane completely impermeable to water, but rather translates into a sevenfold reduction in 
overall water conduction of the astrocyte membrane [62]. We modelled this as a sevenfold increase 
in overall plasma and endfoot membrane resistances (see Supplementary Information S1). As one 
would expect, deletion of AQP4, which are polarized on the astrocyte endfeet, reduces water entry 
into the brain tissue through the endfeet substantially (Figure 2.5a, 90% reduction). Far less intuitive, 
but in agreement with the mentioned experimental study [15], AQP4 deletion also reduces flow 
through IEG markedly (Figure 2.5a, 30% reduction) and flow through the capillary basement 
membrane by 33%. The combined effect is a 43.4% reduction in the total flow rate. When the 
number of astrocytes between arterial and venous PVS is reduced from the baseline number of six to 
two, AQP4 deletion leads to a 14% increase (rather than decrease) in flow through IEG (Figure 2.5b) 
and a reduction of total flow rate by only 7%. The flow rate changes in response to AQP4 knock‐out 
as a function of the astrocyte coverage is shown in Figure 2.5c.  
Deletion of AQP4 also affects flow through gap junctions, as shown in Figure 2.6. Consistent with 
experimental observations of increased inter‐cellular tracer spread in AQP4 knock‐out [63], flow 
through GJ is increased when AQP4 is deleted.  
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Dependence of flow rate on AQP4 polarization 
To assess the influence of AQP4 polarization on flow rate and flow distribution, we distributed AQP4 
uniformly over the entire astrocyte plasma membrane. This is in contrast to the baseline situation in 
which AQP4 populates the endfoot with ten times higher density than it does the remainder of the 
plasma membrane [52]. AQP4 depolarization thus leads to a tenfold increase in resistance to water 
flow through the endfoot compared to baseline (from 6.43 ∗ 10  	
  
   
  
 to 6.43 ∗ 10  	
  
   
  
), while 
the resistance of the remaining membrane is only marginally reduced (from 3.2 ∗ 10  	
  
   
  
 to 
3.13 ∗ 10  	
  
   
  
), owing to its large surface area compared to that of the endfoot. 
Depolarization of AQP4 causes an 89% reduction in water entry from the PVS through the endfoot 
(Figure 2.7). This is accompanied by a 6% increase in inflow through IEG and a 3.7% reduction in flow 
through the capillary basement membrane. The total flow rate is reduced by 15.9%.  
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Figure 2.5: Effect of AQP4 deletion on water flow rate from PVS to the parenchyma through endfoot 
AQP4 channels, inter‐endfeet‐gaps (IEG), capillary basement membrane (BM) and in total. (A) 
Baseline configuration with 6 astrocytes. (B) Configuration with only the two perivascular astrocytes 
with the remaining space filled with other cells not expressing AQP4. (C) Percentage change in flow 
rates from PVS to tissue after AQP4 deletion as a function of the number of AUs included in the 
network. 
 
Influence of capillary water secretion on flow rate 
To test the influence of water secretion from capillaries on changes in flow rate through inter‐
endfeet gaps upon AQP4 deletion, we employed the expanded model shown in Supplementary Fig. 
S2. Having now two sources of inflow into the modelled space between arterial and venous PVS, we 
varied the contribution of capillary secretion to total inflow from 0 to 100% in six steps, recording the 
flow rate through perivascular inter‐endfeet gaps (Figure 2.8). Increasing the contribution of capillary 
secretion reduces inflow through IEG on the arterial side (Figure 2.8a), but does not change outflow 
through perivenous IEG noticeably (Figure 2.8b). 
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Figure 2.6: The effect of AQP4 deletion on water flow rate through the direct GJ connections 
between neighbouring astrocytes in the network. Gap junction positions 1‐2 and 5‐6 refer to the 
connection between the arterial perivascular astrocyte and the first central astrocyte, and between 
the last central astrocyte and venous perivascular astrocyte, respectively. 
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Figure 2.7: Effect of AQP4 depolarization on water flow rate from PVS to the parenchyma through 
endfoot AQP4 channels, inter‐endfeet‐gaps (IEG), capillary basement membrane (BM) and in total. 
Dark bars refer to the baseline state with AQP4 water channels polarized on the endfoot, whereas 
light bars refer to the depolarized state. 
 
Just as in the model without water secretion by capillaries, AQP4 deletion leads to a reduction in flow 
rate through periarterial IEG, as long as the capillaries’ contribution does not exceed 80% of the 
overall inflow into the parenchyma. On the venous side, the capillary secretion rate influences the 
change in flow rate through IEG from baseline to AQP4 knock‐out only slightly. It should be noted 
that the behavior of an incomplete astrocyte network as described in Section 3.2 is more sensitive to 
variations in capillary water secretion. This is discussed in Supplementary Information S3. 
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Figure 2.8: Effect of capillary water secretion rate on the water flow rate through inter‐endfeet gaps 
connecting the perivascular AUs to the (a) arterial and (b) venous PVS, respectively. The left most 
pair of bars in both panels show values for zero water secretion, whereas the right most pairs bars 
give the values for the case where all of the water inflow into the domain stems from capillary 
secretion. The white bars represent the AQP4 deletion state, in which next to the removal of the 
corresponding pathway in the AUs, a reduction of the capillary water secretion by 31% is imposed 
[47]. 
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Sensitivity analysis 
To evaluate the sensitivity of the reported results on the choice of parameter values, we assessed the 
model output for parameter variations within realistic bounds. Results of the sensitivity analysis are 
reported in Supplementary Information S3. Consistent behaviours were noted in all cases, namely a 
significant contribution of the intracellular pathway to total water transport and a reduction in both 
endfoot and IEG flow rates after AQP4 deletion. 
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    Discussion 
We have shown how parallel extracellular and intracellular pathways established by astrocyte 
networks may facilitate bulk fluid flow between adjacent arterial and venous paravascular spaces. 
The unintuitive changes in tracer distribution upon AQP4 deletion observed in vivo can be explained 
by the inhibition of the connection between these parallel pathways. 
The high polarization of AQP4 on astrocyte endfeet may distract from the presence of these water 
channels on the remainder of the cell. The entire astrocyte plasma membrane including all processes 
constitutes an exchange surface that is approximately 400 times larger than the endfoot membrane, 
allowing for substantial water exchange between intra‐ and extracellular spaces even though the 
AQP4 density is ten times lower there than on the endfoot [52]. The importance of such water 
exchange derives from the fact that a) the resistance of the ECS to water flow is higher than that of 
the intracellular space (Table 2.1), and that b) two thirds of the fluid exiting the arterial PVS enter the 
extracellular space (Figure 2.3). To follow the lower resistance intracellular route, water has to first 
pass from the ECS into the cells, which is facilitated by AQP4 expressed on the entire astrocyte 
plasma membrane. 
The significance of this continuous water exchange within the tissue is evidenced when astrocytes in 
the central AUs are progressively replaced by generic cells that do not express AQP4 (Figure 2.4). In 
the situation with only two perivascular AUs (i.e. omitting the contribution of the central astrocytes), 
the total flow rate is cut to 46%, clearly demonstrating the function of the astrocytes in reducing the 
effective resistance of brain tissue to water flow and facilitating fluid transit between adjacent PVS.  
The water exchange between the parallel intra‐ and extracellular routes explains observations by Iliff 
et al. who report that AQP4 knock‐out mice had a lower rate of tracer penetration from the PVS into 
the brain tissue than their wild type counterparts [15]. This implies reduced flow rate through IEG 
upon AQP4 deletion, since tracers cannot pass through AQP4. If intra‐ and extracellular routes served 
as disconnected parallel fluid pathways, deletion of AQP4 would not reduce tracer influx from the 
PVS through the IEG, and the flow rate through IEG would be 1.68 ∗ 10        ⁄  (dashed line in 
Figure 2.3) irrespective of the presence or absence of AQP4. In contrast, deletion of AQP4 in the 
complete network of astrocytes reduces the flow rate through IEG (Figure 2.5a). This is in line with 
the experimental observations. 
The tracer distribution observed in vivo does not only depend on fluid flow through PVS and brain 
tissue, but also on diffusion. To assess the relative contributions of diffusion and advection to tracer 
movement, we consider the Péclet number [64], 
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   =
  
 
,                                              (2.1) 
where L and u are characteristic length and velocity, respectively, and D is the diffusion coefficient of 
the tracer. When this dimensionless number is larger than one, advection (i.e. transport of the tracer 
with the flow) is more important than diffusion. 
Indirect measurements of ISF velocity via tracers have yielded a range of values from 0 to 14.5	
  
   
 
[44, 45]. For the calculation of Pe we consider a range of 1 − 5.5
  
   
, where the lower limit is the 
maximum for grey matter given by Rosenberg et al (Fig. 4 in [44]), and the upper limit the minimum 
given by [45, 65, 66] for the entire brain. With this, Pe in the parenchymal ECS is in the range of 0.005 
to 0.275, while in the PVS it is 0.45 to 25 (see Supplementary Information S2). This means that while 
diffusion dominates tracer distribution in the parenchyma, supply of the tracer through the arterial 
and removal through the venous PVS depend on both advection and diffusion. 
More relevant than the influx of artificial tracers is the fate of natural metabolites in the ISF. These 
are hypothesized to be cleared through the venous PVS [15]. For the baseline astrocyte network with 
functioning AQP4, the ratio of solute transport capacities between PVS and tissue is in the range of 
0.045 to 0.61 for naturally occurring solutes (see Supplementary Information S2). This means that, 
under normal conditions, the solute transport capacity of the tissue (dominated by diffusion) is 
higher than that of the paravascular space (dependent on both advection and diffusion). Thus, the 
PVS appears to be the limiting segment in the solute transport pathway. In absence of AQP4, the 
solute transport capacity of the PVS is further diminished because the fluid flow rate through it is 
reduced (Figure 2.5a). Consequently, even though metabolites are transported largely by diffusion in 
the brain tissue, their removal is nevertheless dependent on bulk flow through the PVS, and in turn 
on the net flow of water through both intra‐ and extracellular routes in the tissue. This also explains 
in vivo experimental observations of reduced solute clearance from the tissue in AQP4 knock‐out 
mice [15]. 
There are indications that the fluid flow rate through the PVS is increased during sleep [67], 
presumably due to reduced resistance in the ECS as a consequence of an increase in volume of this 
space [67]. In our model, the reported 60% increase in ECS volume [67] translates to a 46% reduction 
of ECS resistance. Even though increased ECS volume necessitates a decrease in intracellular volume 
and thus an increase in the corresponding water pathway’s resistance (by 25%), the overall 
resistance between arterial and venous PVS drops, leading to a 36% increase in total flow rate. This in 
turn raises the ratio of solute transport capacity in the PVS to that in the tissue to a range of 0.048 to 
0.77 for naturally occurring solutes (see Supplementary Information S2). This means that during 
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sleep, the clearance rates of larger metabolites such as amyloid beta are closer to their limit set by 
diffusion in the brain tissue.  
Para‐arterial water inflow and water secretion from capillaries into the parenchyma may coexist. 
Under the here investigated conditions, the observations of reduced tracer influx into the ISF in 
animals lacking AQP4 are reproduced as long as the arterial PVS is the main source of water influx 
into the parenchyma. Under nominal conditions (Figure 2.8), this is even the case for ratios of 
capillary secretion to inflow from PVS of up to 4:1. At higher ratios, water is drained through the 
arterial PVS rather than supplied, and AQP4 deletion increases drainage.  
The relevance of this work derives from the fact that it is currently not possible to measure 
interstitial fluid flow directly in vivo, but that flow rates have to be inferred from the evolution of 
tracer distribution patterns. This also implies that direct quantitative experimental validation of our 
model will be extremely challenging. However, our results are in agreement with qualitative 
experimental observations: 
We show that deletion of AQP4 channels results in a reduction of IEG flow rate and increase in the 
flow rate through GJs, both of which have also been observed in vivo in AQP4 knock‐out rodents [15, 
63]. Our parametric variations of the number of astrocytes and AQP4 distribution provide a rationale 
for the makeup of the fluid pathway structures, demonstrating that both AQP4 polarization on the 
astrocyte endfeet and a dense astrocyte network are required for optimal water transport between 
paravascular spaces. 
The flow distribution between intra‐ and extracellular pathways is determined by the resistances of 
the individual routes. Inadequate choices of resistance values could yield incorrect results. To reduce 
this possibility, we performed a sensitivity analysis as documented in Supplementary Information S3. 
This analysis shows that our model is robust with respect to variation of parameters within realistic 
bounds. 
Our model considers a pressure gradient between the arterial and venous PVS as the driving force 
behind the observed fluid flow. This gradient can be viewed as the result of the superposition of all 
driving forces acting on water on its way from arterial to venous PVS, including possible hydrostatic 
pressure caused by arterial wall pulsation [20, 68]. Since the magnitude of the gradient is unknown, 
we prescribe a value that yields a baseline extracellular fluid flow velocity in line with experimental 
estimates in grey matter [44]. As a consequence, the absolute values of the here reported flow rates 
should also be seen as estimates. However, as discussed in Supplementary Information S3, the 
conclusions of the investigations are not affected by reasonable changes of the gradient magnitude.  
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More important than its value is the question whether such a gradient exists in the first place. The 
reduction of the rate of tracer distribution and metabolite clearance in mice lacking AQP4 appears to 
necessitate bulk flow from arterial to venous PVS, and with it a corresponding driving force gradient. 
Should it be the case that AQP4 deletion has secondary effects that influence fluid flow, other 
explanations for the observed tracer spread would have to be considered. These include flow‐
induced mixing and dispersion in the PVS, as well as increased effective tracer and metabolite 
diffusivity in the parenchyma due to Taylor dispersion [69]. Both effects could be caused by arterial 
pulsation and do not necessitate bulk flow.  
In summary, while diffusion is the main mode of solute transport in brain tissue, it does not suffice to 
explain effective metabolite clearance into the venous paravascular space observed in tracer studies 
in vivo. Other modes of transport need to be taken into account as well. We have shown with this 
computational study that if there is bulk flow between arterial and venous paravascular spaces, 
astrocyte networks may serve as low resistance pathways to water flow that enhance metabolite 
clearance through a parallel, extracellular route. Observations of reduced metabolite clearance in 
animals lacking AQP4 may be explained by diminished bulk flow caused by inhibition of the 
interconnection between the astrocyte networks and the extracellular route. 
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Supplementary Information – Estimation of flow resistances 
Table 2.2 in the main text lists all parameters used, accompanied by the corresponding reference or 
associated equation for derived quantities. For ease of understanding, the most prominent spatial 
dimensions used to obtain the model parameters are illustrated in the Supplementary Fig. S1. 
 
Supplementary Figure S1: Dimensions used to obtain the model parameters. Nomenclature and 
values of these dimensions are given in Table 2.2. 
 
A pressure difference of 226 Pa (1.7 mmHg) between arterial and venous PVS is required to yield the 
baseline interstitial fluid flow velocity of     _         = 1
  
   
 (see Table 2.2). This pressure 
difference should be seen as the net value produced by the superposition of all relevant hydrostatic 
and osmotic pressure sources, including arterial wall pulsations[20, 68]. The stated 1.7 mmHg appear 
reasonable compared to the 17 mmHg blood pressure drop from arteriole to venule [70].  
Simplifications 
Laminar flow is assumed in the ECS, which is supported by the low Reynolds number in that space,  
    =
    
 
< 5 ∗ 10  , (S1.1) 
Parameters
Pressure gradient between arterial and venous paravascular spaces 
Estimation of the bulk flow resistance in channel structures of the brain micro-
environment including extracellular and intra-cellular pathways. 
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where u is the expected flow velocity in the range of 5.5 − 14.5	
  
   
 [45], Dh is the hydraulic 
diameter of the fluid path (taken to be equal to HECS), ρ and µ are, respectively, density and dynamic 
viscosity of the interstitial fluid. 
The ECS can be viewed as a tortuous pathway that winds around cellular elements in the tissue. This 
may have two effects: first, tortuosity increases the effective length of a channel compared to a 
straight one, which is typically accounted for by correcting the straight length by a tortuosity 
coefficient; second, local curvatures may induce secondary flow structures that would dissipate 
energy and increase the effective resistance of the path. However, this second effect can be 
neglected herein, as demonstrated by the very low Dean number (Dn), 
    =
      
 
 
    
 
 
 
  
< 10  , (S1.2) 
where R is the characteristic radius of curvature of the pathway, which we considered to be equal to 
half of the cell process diameter (DPR). Hence, we may retain the channel flow equations to derive 
the resistances of the different flow pathways, solely correcting them for the increase in effective 
path length.  
Derivation of       
With the above simplifications, the resistance of one ECS pathway,     , , can be obtained from the 
analytical expression for a straight channel [71],  
     ,  =
12μτ   (
   
2 )
H   
 W    
 (S1.3) 
where τECS is the ECS channel tortuosity, with the product τ   (
   
 
) representing the effective 
length of an ECS channel spanning half of one AU. The resistance value for one ECS pathway obtained 
using Equation (S1.3) corresponds to a single route through the ECS. In practice, there are multiple 
ECS routes within a single astrocyte unit (AU). Using the ECS volume fraction       and characteristic 
dimensions reported in Table 2.2, we can determine the volume of characteristic single ECS 
route,	    , , and deduce the total number of routes,      , required to match the total ECS volume, 
    ,  ,  from the ratio of the two volumes 
      =
    , 
    , 
. (S1.4) 
Assuming that these individual ECS routes carry water in parallel, the overall ECS resistance of half 
the length of one AU can be approximated as: 
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      =
    , 
    
. (S1.5) 
Estimation of the inter-endfeet gap resistance,	       
Applying the analytical expression for the resistance of a straight channel (Equation (S1.3)), and 
assuming the length, height and width of the IEG to be given by the endfoot thickness,     , ECS 
channel thickness,     , and characteristic length of the endfoot contact area,     , we obtain: 
      =
12μ   
    
    
. (S1.6) 
 
Tortuosity is assumed to be 1, since the IEG is very short. Based on the observation that astrocyte 
endfeet can completely enwrap individual capillaries [42], the characteristic endfoot length is given 
the same value as the circumference of a capillary,  
     =  	          . (S1.7) 
 
Estimation of the capillary basement membrane resistance, RBM 
To calculate the overall resistance of the capillary basement membrane layers in one AU, we need an 
approximation of the number of capillaries available in the astrocyte domain volume, ncapillary. To this 
end, we consider the capillary volume fraction           	in brain tissue:  
            =
           ∗    
          , 
, (S1.8) 
where     is the astrocyte domain volume and           ,  the characteristic volume of a single 
capillary segment of the length of one AU.            evaluates to approximately 1, which means that 
the overall capillary segment length in an AU sized volume of brain tissue has the length of one AU. 
When we state in the description of our model that each AU is associated with one capillary, we refer 
to this situation.  
The capillary basement membrane is rather dense. For half the length of one AU, its resistance can 
be calculated as  
     =
   
2 	 
   	   	          
, (S1.9) 
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where     is the permeability of the capillary basement membrane and     is its cross‐sectional 
area of this membrane calculated based on the characteristic dimensions reported in Table 2.2. 
Estimation of intra-cellular resistances, RPR 
Following a similar approach, the intracellular resistance of an astrocyte process spanning half the 
length of one AU is obtained from resistance of cylindrical pipe of diameter,     , and effective length 
    (
   
 
):  
     =
128     (
   
2 )
    
  = 2.56 ∗ 10
  	
  
   
  
. (S1.10) 
The above equation assumes free fluid flow through the entire intra‐cellular space. In practice, the 
volume fraction of the cytosol of retinal glial cells is > 50% [72]. Inferring a similar distribution for 
astrocytes would bring the intracellular pathway resistance up to 6.45 ∗ 10  	
  
   
  
. However, as 
demonstrated in our sensitivity analysis (Supplementary Information S3), this has hardly any impact 
on the reported results due to the dominant effect of the plasma and endfoot membrane 
resistances.  
Contribution of AQP4 channels to the membrane resistance 
In our model, we divide the plasma membrane resistance into two components, each representing 
the plasma membrane in half of the astrocyte unit. Knowing the conductivity of a single AQP4 
channel, CAQP4, to be 24*10
‐14 cm3/s [51], the contribution of AQP4 to the plasma membrane 
resistance is given by  
    _   =
1
      _   	 
   
2  	      
, (S1.11) 
where dAQP4_PM is the density of AQP4 over the plasma membrane (not including the endfoot) and 
SPM/2 is the surface area of the plasma membrane in half of an AU. The AQP4 contribution to the 
resistance of the endfoot plasma membrane, REF_AQ, is obtained according to equation (S1.11) as well, 
using the density of AQP4 on the endfoot, dAQP4_PM, and estimating the endfoot surface area as 
     =     	     =              	          . (S1.12) 
This estimation makes use of the observation that astrocyte endfeet can completely enwrap 
individual capillaries with approximately the same width as the capillary diameter [42].  
Estimations of the cell membrane resistances
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Overall membrane resistance and its change after AQP4 deletion 
The overall resistance of the astrocyte plasma membrane in one astrocyte unit is given by 
     =
    _       _  
    _        _  
, (S1.13) 
where    _    is the resistance of AQP4 channels on the plasma membrane obtained from equation 
(S1.11) and    _   is the resistance of the membrane itself. While the contribution of the AQP4 
channels was estimated above, that of the membrane still needs to be determined. We make use of 
the fact that after AQP4 deletion, the overall resistance        /  is seven times higher than the 
resistance in the presence of AQP4 channels [62], RPM. Together with equation (S1.13), this yields the 
following relationships:  
        /  =    _  , (S1.14) 
        /  = 7   , (S1.15) 
from which we can deduce 
     =
 
 
   _   . (S1.16) 
The overall resistance of the endfoot membrane, REF, can be derived similarly.  
 
The typical hydraulic diameter of a gap junction channel, DGJ, is 2.5‐4.5 nm [43]. As GJ channels 
connect two plasma membranes of 4‐6 nm thickness, Hmembrane [54], their length is approximately in 
the range of 8‐12 nm. Navier‐Stokes equations are principally only valid for continuum fluids. 
Nevertheless, they have been shown to provide good estimates for water dynamics in nanochannels 
[73], with diameters as small as 5‐10 times the width of an individual fluid molecule’s diameter [74]. 
Accordingly, we estimate the resistance of single GJ channel based on the assumption of Hagen‐
Poiseuille flow through a circular cylindrical channel with diameter DGJ and length 2Hmembrane:  
    ,  =
    (          )
    
  . (S1.17) 
The total resistance of a gap junction is obtained by considering the density of GJ channels dGJ of 
200	     over a contact area SGJ of 1	  
  estimated from the figures in the reference [55]: 
     =
   , 
    ∗    
. (S1.18) 
  
Gap junction resistance
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To assess the effect of possible water secretion by capillaries[5], we introduce an expanded version 
of the model described in the manuscript. This is shown below in Supplementary Fig. S2. Water 
secretion by capillaries is enforced by flow sources (or current sources in the electric analogue). 
There is one source per AU length of capillary, thus 6 sources with the same secretion rate in total. 
The secretion rate and the pressure drop from arterial to venous PVS are set such that the baseline 
parenchyma flow rate (combination of the total influx through arterial PVS, including IEG, EF and BM, 
and secretion by capillaries) is always maintained. Thus when the secretion rate is step‐wise 
increased from its nominal value of zero, the pressure drop from arterial to venous PVS is decreased 
to keep the baseline parenchyma flow rate (Supplementary Table S1). Even when capillary secretion 
accounts for the entire parenchymal water influx, a pressure gradient from arterial and venous PVS is 
still necessary to ensure the prescribed ISF flow velocity. In absence of this gradient, there would be 
outflow through both arterial and venous PVS, yielding zero net ISF velocity.  
When the effect of AQP4 deletion is studied, the secretion rate is reduced by 31%[47] without 
further adjustment of the above‐determined inter‐PVS pressure drop (Supplementary Table S1). This 
31% reduction is based on observations in glial‐conditional AQP4 knockout mice after systemic 
hypoosmotic stress[47]. Under normal osmotic conditions, one can expect less reduction in the 
secretion rate upon AQP4 deletion, since water secretion is an active process that can be 
upregulated. We investigate the effects of both higher and lower rates of secretion reduction in the 
sensitivity analysis in Supplementary Information S3. 
 
 
 
 
 
Water secretion by capillaries
37 
 
 
Supplementary Figure S2: Electrical analogue model of cerebral water transport between arterial and 
venous paravascular spaces (PVS) including water secretion sources at the capillary level in addition 
to the elements described in Figure 2.2 (main text). Definitions of the abbreviations referring to the 
physical model domain are given in Figure 2.1 (main text). Arterial and venous paravascular spaces 
are connected by resistances (R) representing the resistance to fluid flow of capillary basement 
membrane (BM) segments and astrocyte units (AU). Each astrocyte unit (AU) includes resistances of 
both intracellular (cell processes, PR) and extracellular (ECS) pathways which are linked by 
membrane resistances, namely those of the astrocyte endfoot membrane (EF) and the remainder of 
the astrocyte plasma membrane (PM). Since these membrane resistances are dependent on the 
AQP4 expression level, they are indicated as variable resistances (arrows). Gap junction (GJ) 
resistances connect the intracellular spaces of two neighbouring astrocytes. 
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Supplementary Table S1: Rates of water secretion from capillaries in normal and AQP4 knock‐out 
cases for different levels of contribution of secretion to overall water influx. The corresponding 
pressure drop between arterial and venous paravascular spaces is also reported. 
Capillary secretion rate 
as fraction of overall 
water inflow rate  [%] 
Inter‐PVSs  
pressure drop 
[Pa] 
Capillary secretion rate 
in normal case 
[10   	
   
 
] 
Capillary secretion rate 
in AQP4 knock‐out 
case [	10   	
   
 
] 
0 226 0 0 
20% 202.98 0.91 0.63 
40% 180.09 1.82 1.26 
60% 157.71 2.72 1.88 
80% 134.32 3.63 2.5 
100% 111.94 4.54 3.13 
 
To evaluate the relative contribution of advection and diffusion to solute transport in the ECS, we 
consider the non‐dimensional Péclet number: 
    =
  
 
, (S1.19) 
where L is the characteristic length, u is the flow velocity and D is the diffusion coefficient of the 
solute. For naturally occurring solutes and tracers commonly used to study ISF flow in the brain, D 
ranges between 5*10‐11 and 5*10‐10 m2/s [35]. As these solutes are either produced throughout the 
tissue or injected at a given location in the tissue, we set the diffusion length to half the distance 
between arterial and venous PVS, namely 
   
2  . For the ISF flow velocity, there is a range of 
reported values from 0 − 	1	
  
   
 specifically for grey matter[44] to brain averaged values of 
5.5 − 14.5	
  
   
 [45]. For the calculation of Pe we consider a range of 1 − 5.5
  
   
, where the lower 
limit is the maximum for grey matter given by Rosenberg et al (Fig. 4 in [44]), and the upper limit the 
minimum given by [45, 65, 66] for the entire brain. This yields Pe in the range of 0.005 to 0.275 in the 
ECS. Solute transport in the ECS is thus dominated by diffusion. 
For the corresponding analysis in the PVS, we need to determine the bulk flow velocity therein based 
on the integrated value of water transfer between PVS and parenchyma. We consider a PVS segment 
Supplementary Information – Solute transport analysis 
Relative role of diffusion and advection in solute transport in the tissue and PVS 
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of length corresponding to that of a penetrating arteriole in the rodent cortex,      = 500   [49]. 
Considering the flow rate from PVS to tissue through a single astrocyte endfoot and its neighbouring 
inter‐endfeet‐gap and integrating this value over the length of considered paravascular space using 
the characteristic dimensions reported in Table 2.2, we obtain 
      =
    
(        )
           
   
     
          	    
. (S1.20) 
This yields fluid flow velocity between 0.9 − 5
  
 
 in the PVS velocities of 1 ‐ 5.5 
  
   
 in the ECS. 
Accordingly, the Péclet number ranges between 0.45 and 25 in the PVS for a diffusion length of half 
the PVS length, 
    
2  . Advection must thus not be neglected in the PVS, and is the dominant factor 
in the transport of large solutes such as amyloid beta. 
We use the metrics of convective and diffusive fluxes to calculate the upper limit of solute transport 
through ECS and PVS, referring to this limit as solute transport capacity. Convective and diffusive 
fluxes are defined as: 
 
   =    , 
   =   
  
  
, 
(S1.21) 
where D is the solute’s diffusion coefficient, A the surface area perpendicular to the desired flux 
direction, C the solute concentration, 
  
  
 the concentration gradient in the flux direction and u the 
fluid velocity.  
To compare the PVS and tissue transport capacities, let us consider a segment of PVS of length  PVS as 
illustrated in Supplementary Fig. S3, and the solute fluxes in and out of that segment. Since solutes 
could enter the PVS segment from whole the length of it, the diffusion length in PVS is taken as 
    
2  , then the flux of solutes through this segment of PVS is governed by advection and diffusion 
as follows: 
      =   _    +   _    =      	     	     	  +  	     	     	
 
    
2 
, (S1.22) 
where uPVS is the velocity in the PVS and Ppvs and Hpvs are the PVS circumference and thickness, 
respectively. Solutes (metabolites) are produced throughout the tissue and enter the PVS through 
IEG. Their diffusion length is thus taken as 
   
2  . The solute flux from tissue to PVS is then written 
as: 
Solute transport capacity in ECS and PVS
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 	     =   _    +   _    =      	     	     	     	  +  	     	     	     	
 
   
2 
, (S1.23) 
where the product           is the surface of the PVS segment under consideration and       the 
proportion of PVS surface covered by IEG which allows the movement of solutes between PVS and 
tissue. 
The ratio of the solute transport capacity in PVS to tissue becomes: 
   =
    
    
=
     	     	     	  +  	     	     	
 
    
2 
    	     	     	     	  +  	     	     	     	
 
   
2 
. (S1.24) 
Since we have already discussed the Péclet number in PVS and ECS, we rewrite the above equation 
based on this number definition for PVS and ECS: 
   =
    
    
=
     	     	  1 +
1
     
 	
2	    
   
 	     	(1 +      )
. (S1.25) 
 
 
Supplementary Figure S3: Dimensions used to obtain the solute transport capacity ratio in equation 
(S1.24) and (S1.25). C represents the solute concentration in the center of the tissue. 
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Solute transport capacity in the awake state 
Here we consider the thickness of paravascular space,      , to be 1 µm [19],     =1/25 referring to 
Table 2.2,      = 0.9 − 5	
  
 
 as estimated in S2.1, and the diffusion coefficients of natural solutes in 
the brain and of common tracers, D, to be in the range of 5*10    − 5 ∗ 10   
  
 
 [35]. With these 
values, theadvective to diffusive transport rate ratio ranges between: 
 
  = 0.045− 0.61. 
 
(S1.26) 
In the case of AQP4 knock‐out, this ratio decreases due to the 44% reduction in overall water flow 
rate from PVS to tissue (see Results section):  
        /  = 0.038− 0.39. (S1.27) 
Solute transport capacity during sleep 
It has been reported that ECS volume increases by 60% in mice during sleep. Based on a 1:4 initial 
ratio of ECS to intracellular space volume, this translates to a 15% reduction of intracellular volume 
during sleep. Under the assumption that the volume changes are caused by equal relative changes in 
all relevant dimensions, the ECS resistance decreases by 46% (equation (S1.3)) while the resistance of 
the intracellular pathway increases by 25%. The combined effect is an increase of the total flow rate 
from PVS to tissue by 36% (see Supplementary Fig. S4). The solute transport capacity then ranges 
between 0.048 – 0.77.  
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Supplementary Figure S4: Flow rates from PVS to tissue through IEG, endfoot, capillary basement 
membrane and in total during wake (dark bars) and sleep states (light bars).  
 
Supplementary Information – Sensitivity analyses 
We performed sensitivity analyses to ensure that the conclusions drawn in this work are not biased 
by the choice of model parameter values. Analyses for resistances are summarized in Supplementary 
Table S2, where flow rates under normal and AQP4 knock‐out conditions are reported for the listed 
upper and lower bounds of parameters. The reported flow rates are normalized by the total flow rate 
under normal conditions. For the GJ resistance, the upper parameter bound was set to infinity, 
modelling the absence of GJs, while the lower bound was set to the endfoot membrane resistance, 
as this is the most water conductive part of the plasma membrane. The intracellular space is not just 
a fluid filled void; the volume fraction occupied by cell organelles and other solid components that 
offer resistance to water flow have to be taken into account. Thus, the upper bound of intracellular 
resistance was set based on the reported approximations of the cytosol volume fraction in glial cells 
(the corresponding calculations are described in Supplementary Information S1). Other resistances 
were varied by one order of magnitude in either direction of their respective nominal value.  
Supplementary Table S3 summarizes the results of the sensitivity analyses for changes in the baseline 
ISF velocity based on which the pressure drop between arterial and venous PVS is derived. Since the 
nominal ISF velocity used in the main text is at the very lower end of the values reported in the 
literature, we analysed increased velocities up to 5.5	
  
   
. We do not consider higher values to be 
representative of grey matter, as they are derived from measurements on the entire brain and thus 
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include the effects of white matter as well as paravascular spaces. While absolute flow rates change, 
normalized values and their relative change upon AQP4 deletion are not affected. This is due to the 
linearity of the model for the nominal ISF velocity and inter‐PVS pressure drop (in the absence of 
capillary secretion described in Supplementary Information S1).  
Supplementary Table S4 shows the results of sensitivity analyses for different values of capillary 
water secretion reduction after AQP4 deletion in the expanded model described in Supplementary 
Information S1. The nominal value for the secretion reduction is 31% based on experimental 
evidence [47]. As mentioned in the model description, this nominal value is likely too high. We have 
thus set the lower bound in the sensitivity analysis to 0%, i.e. no reduction in water secretion. The 
upper bound is set to 50%. The expected reduction of flow rate through the periarterial IEG in the full 
network of astrocytes after AQP4 deletion and its increase in the incomplete network are 
reproduced with all levels of secretion reduction as long as the PVS is responsible for at least 60% of 
the water supply to the parenchyma.  
The conclusions drawn in this work are that a) flow rate through IEG is reduced upon AQP4 deletion 
in a complete astrocyte network and b) that the flow rate is not reduced in an incomplete network 
without central astrocytes when AQP4 is deleted. The sensitivity analyses reported in Supplementary 
Tables S2, S3 and S4 show that both observations hold for all considered parameter variations as long 
as the PVS is the main source of water flux into the parenchyma.   
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Supplementary Table S2: Sensitivity of the results to changes in resistance values. Results for both 
full and incomplete networks are provided as flow rates normalized by the corresponding total flow 
rate under normal conditions. 
Resistance 
Value 
[
  
   
  
] 
Model 
condition: 
Normal or 
AQP4‐/‐ 
Normalized flow rates 
Full network of astrocytes 
(6AU) 
Incomplete network  
(2 perivascular AU) 
IEG 
End‐
foot 
BM 
Total 
IEG End‐
foot 
BM Total 
      
     
     
    
     
      
    
 
 
Baseline 
resistance 
values 
1.12 ∗ 10  
3.2 ∗ 10  
6.43 ∗ 10  
1.35 ∗ 10  
2.56 ∗ 10  
9.5 ∗ 10  
7.1 ∗ 10  
Normal 0.66 0.22 
 
1 0.67 0.21 
 
 
0.12 
0.13 1 
 
0.11 
0.08 AQP4‐/‐ 0.46 0.024 0.57 0.76 0.038 0.93 
      
lower 
bound 
1.12 ∗ 10  
Normal 0.93 0.043 0.27 1 0.93 0.043 0.03 1 
AQP4‐/‐ 0.83 0.006 0.02 0.87 0.95 0.007 0.03 0.983 
upper 
bound 
1.12 ∗ 10  
Normal 0.17 0.53 0.3 1 0.17 0.04 0.04 1 
AQP4‐/‐ 0.13 0.068 0.18 0.37 0.28 0.011 0.05 0.90 
     
     
lower 
bound 
3.2 ∗ 10  
6.43 ∗ 10  
Normal 0.25 0.69 0.05 1 0.25 0.69 0.06 1 
AQP4‐/‐ 0.2 0.095 0.04 0.33 0.5 0.23 0.1 0.85 
upper 
bound 
3.2 ∗ 10  
6.43 ∗ 10  
Normal 0.82 0.03 0.14 1 0.82 0.026 0.14 1 
AQP4‐/‐ 0.73 0.005 0.12 0.86 0.84 0.004 0.14 0.99 
    
lower 
bound 
6.43 ∗ 10  
Normal 0.65 0.22 0.12 1     
AQP4‐/‐ 0.47 0.026 0.08 0.58     
upper 
bound 
→ ∞ 
Normal 0.67 0.22 0.12 1     
AQP4‐/‐ 0.45 0.022 0.08 0.54     
   
 upper 
bound 
6.45 ∗ 10  
Normal 0.66 0.22 0.12 1 0.67 0.21 0.12 1 
AQP4‐/‐ 0.48 0.023 0.08 0.59 0.76 0.04 0.13 0.93 
      
lower 
bound 
9.5 
Normal 0.67 0.21 0.11 1 0.68 0.2 0.12 1 
AQP4‐/‐ 0.48 0.021 0.07 0.56 0.78 0.038 0.13 0.94 
upper 
bound 9.5 ∗ 10  
Normal 0.57 0.25 0.16 1 0.57 0.26 0.17 1 
AQP4‐/‐ 0.42 0.03 
0.12 0.57
5 
0.68 0.04 
0.18 
0.9 
 
    
 
lower 
bound 
7.1 ∗ 10  
Normal 0.35 0.13 0.52 1 0.32 0.1 0.58 1 
AQP4‐/‐ 0.27 0.013 0.41 0.7 0.35 0.01 0.59 0.96 
upper 
bound 
7.1 ∗ 10  
Normal 0.74 0.24 0.01 1 0.75 0.24 0.01 1 
AQP4‐/‐ 0.51 0.026 0.01 0.54 0.86 0.04 0.02 0.92 
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Supplementary Table S3: Sensitivity of the reported flow rates to changes in nominal ISF flow velocity 
and corresponding  inter‐PVS pressure drop. Results for both full and incomplete networks are 
provided as flow rates normalized by the corresponding total flow rate under normal conditions. 
     
Inter‐PVS 
Model 
condition: 
Normal or 
AQP4‐/‐ 
Normalized flow rates  
Pressure 
drop 
Full network of astrocytes (6 
AUs) 
Incomplete network  
(2 perivascular AUs) 
[Pa] 
IEG 
End‐
foot 
BM Tot
al 
IEG End‐
foot 
BM Total 
Baseline 
value 
1	
  
   
 226 
Normal 0.66 0.22 0.11 1 0.67 0.21 0.12 1 
AQP4‐/‐ 0.46 0.024 0.08 0.57 0.76 0.038 0.13 0.93 
 2.5	
  
   
 565 
Normal 0.66 0.22 0.11 1 0.67 0.21 0.12 1 
AQP4‐/‐ 0.46 0.024 0.078 0.57 0.76 0.04 0.13 0.93 
 5.5	
  
   
 1243 
Normal 0.66 0.22 0.11 1 0.67 0.21 0.12 1 
AQP4‐/‐ 0.46 0.024 0.078 0.57 0.76 0.04 0.13 0.93 
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Supplementary Table S4: Sensitivity of the reported IEG flow rates to changes in capillary water 
secretion reduction after AQP4 deletion. Results for different capillary secretion rates and for both 
full and incomplete networks are provided. 
  Flow rates through arterial IEG [     	
   
 
] 
  Full network of astrocytes (6 AUs) 
Incomplete network  
(2 perivascular AUs) 
Reduction in 
capillary 
water 
secretion 
after AQP4‐/‐ 
[%] 
Capillary 
secretion as 
fraction of 
total inflow 
[%] 
0 20 40 60 80 100 0 20 40 60 80 100 
Model 
condition: 
Normal or 
AQP4‐/‐ 
            
 0 
Normal 3 2.4 1.8 1.2 0.6 0 1.4 0.95 0.52 0.08 ‐0.36 ‐0.79 
AQP4‐/‐ 2.1 1.53 0.97 0.4 ‐0.17 ‐0.73 1.6 1.08 0.57 0.05 ‐0.47 ‐0.99 
Nominal 
value 
31 
Normal 3 2.4 1.8 1.2 0.6 0 1.4 0.95 0.52 0.08 ‐0.36 ‐0.79 
AQP4‐/‐ 2.1 1.64 1.18 0.73 0.27 ‐0.18 1.6 1.19 0.78 0.38 ‐0.03 ‐0.44 
 50 
Normal 3 2.4 1.8 1.2 0.6 0 1.4 0.95 0.52 0.08 ‐0.36 ‐0.79 
AQP4‐/‐ 2.1 1.7 1.32 0.93 0.54 0.15 1.6 1.26 0.92 0.58 0.24 ‐0.1 
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Chapter 3 Glymphatic solute transport does not require bulk flow 
This chapter has been published as: 
Asgari, Mahdi, Diane de Zélicourt, and Vartan Kurtcuoglu. "Glymphatic solute transport does 
not require bulk flow." Scientific Reports 6 (2016): 38635. 
 
     Abstract 
Observations of fast transport of fluorescent tracers in mouse brains have led to the hypothesis of 
bulk water flow directed from arterial to venous paravascular spaces (PVS) through the cortical 
interstitium. At the same time, there is evidence for interstitial solute transport by diffusion rather 
than by directed bulk fluid motion. It has been shown that the two views may be consolidated by 
intracellular water flow through astrocyte networks combined with mainly diffusive extracellular 
transport of solutes. This requires the presence of a driving force that has not been determined to 
date, but for which arterial pulsation has been suggested as the origin. Here we show that arterial 
pulsation caused by pulse wave propagation is an unlikely origin of this hypothetical driving force. 
However, we further show that such pulsation may still lead to fast para‐arterial solute transport 
through dispersion, that is, through the combined effect of local mixing and diffusion in the para‐
arterial space. 
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Computational modeling, dispersion, paravascular transport, glymphatic system, cerebrospinal fluid
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    Introduction 
Recent observations of fast paravascular transport of exogenous fluorescent tracers in the mouse 
cortex have led to debates about the existence of bulk fluid flow through the brain’s extracellular 
space (ECS) [75]. Such bulk flow, directed from arterial to venous paravascular spaces, has been 
suggested to play an important role in cerebral metabolite clearance, with more efficient removal of 
solutes during sleep, and reduced clearance in aquaporin‐4 (AQP4) deficient animals [15, 67]. 
Since cerebral water flow cannot be observed directly in vivo with sufficiently high resolution, the 
spatial and temporal variation of tracers is used as a surrogate marker for fluid motion. If a given 
tracer distributes more quickly than predicted by its diffusion coefficient, and if the distribution 
pattern is non‐uniform, directed transport of the tracer by bulk water flow is usually suspected [9]. 
However, similar distribution patterns can also be caused by dispersion without directional bulk flow. 
Here, dispersion refers to transport of solutes by the combined effect of diffusion and macroscopic 
fluid motion with zero mean (see Figure 3.1). For instance, cyclic deformation of the human brain 
induced by cardiovascular and respiratory action induces ventricular cerebrospinal fluid (CSF) motion 
with close to zero net flow that leads to substantial dispersion [30]. Similarly, dispersion occurs in the 
spinal canal through oscillatory CSF motion [29]. 
In the absence of tools for measuring water flow directly, it is not straight forward to determine 
whether fast solute transport is the result of bulk flow or dispersion. Computational modeling can be 
used to assess the plausibility of either mode. We have shown previously that under the assumption 
of a para‐arterial to para‐venous driving force, the observed fast transport of solutes can be 
explained by bulk water motion, provided that there is substantial intracellular water flow through 
astrocytes [76]. It has been suggested, but not demonstrated, that arterial pulsation could generate 
the required driving force [20, 68]. 
Here we show using a new set of computational models that arterial pulsations caused by pulse wave 
propagation are unlikely to generate such driving force. Much rather than being the origin of bulk 
flow, we demonstrate that arterial pulsation may lead to fast paravascular solute transport by 
dispersion. 
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Figure 3.1: Illustration of the differences between solute transport by diffusion, advection and 
dispersion in the absence of net flow. In this hypothetical setup, which is not meant to represent 
paravascular transport, a drop of solute (red circle) is injected into a fluid filled channel at time t0 (left 
column). In the top row, the fluid is still and the solute may solely be transported by diffusion, 
whereas in the two other conditions (advection, middle row, and dispersion, bottom row), two stir 
bars rotating counterclockwise induce a continuous fluid motion with zero net flow. The temporal 
evolution of the solute concentration (red: high, blue: low concentration, white: no solute) is 
illustrated in the following columns at equally spaced time points, t   … . Pure diffusion leads to slow 
solute transport. Advection by itself moves the solute much faster, but, in absence of any diffusion, 
confines the drop to the influence region of the first stir bar. In contrast, the combined effects of 
advection and diffusion, i.e. dispersion, result in fast solute transport from left to right, even though 
there is no (time‐averaged) net flow of the liquid. 
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     Methods 
We designed two distinct computational models: The first one was used to assess the impact of 
arterial pulsation alone on water and solute dynamics in the para‐arterial space. With the second 
model we explored solute transport from the para‐arterial to the para‐venous space through the 
cortical interstitium. All model parameters are listed in Table 3.1. 
Table 3.1: Model parameters. 
Parameter Value Unit Reference 
3D Axisymmetric model of water and solute dynamics in arterial PVS 
Arterial wall distension wave 
Wave amplitude 0.5 μm  [68] 
Wave propagation velocity 1 m s⁄  [28] 
Wave frequency 10 1  ⁄  [68] 
Wavelength 0.1 m   
Dimensions 
Cortical arteriole diameter 23 μm  [68] 
PVS model domain length (L) 150‐250 μm  [77] 
PVS model domain width (W) 10 μm  [15] 
PVS domain properties 
PVS hydraulic permeability (K) 2 · 10    m     ∙ ⁄  [28] 
PVS porosity ( ) 0.2 ‐ [28] 
Cerebrospinal fluid properties 
Density ( ) 1000 kg m  ⁄  [34] 
Dynamic viscosity (μ) 0.001 Pa ∙s [34] 
1D model of solute transport in PVS and ECS 
Half‐length of the paravascular space of a penetrating vessel 250 μm  [49] 
Thickness of the glia limitans 1 μm  [42] 
Characteristic distance between arteriole and venule PVS 300 μm  [24] 
IEG width 20 nm  [15, 41] 
Characteristic ECS channel width 20 nm  [56] 
ECS volume fraction ( ) 0.2 ‐ [35] 
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          Model of water and solute dynamics in the para-arterial space 
We consider a three‐dimensional axisymmetric channel with a pulsating boundary as a simplified 
representation of a bifurcation free segment of cortical para‐arterial space. A two‐dimensional 
illustration of the correspondence between the channel – henceforth referred to as the model 
domain – and the represented paravascular space segment is shown in Figure 3.2.  
The domain length corresponds to the characteristic bifurcation free length of a penetrating arteriole 
in the mouse cerebral cortex. The total length of a cortical penetrating arteriole is approximately 500 
µm [49] (Table 3.1), but the longest bifurcation free segment is clearly shorter [49, 77]. According to 
Yoshihara et al. [77] and private communications with the senior author of that study, Dr. Kazuto 
Masamoto, arterioles in the diameter range of 24.2 ± 2.4 μm have an average segment length of 234 
μm. To account for variability and to probe the influence of segment length on the reported results, 
we consider a range of domain lengths from 150 to 250 μm. 
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Figure 3.2: Schematic of cerebral arterial and venous paravascular spaces. The arterial PVS extends 
from the subarachnoid space (SAS) and follows the penetrating vessel into the tissue. This space is 
restricted on the one side by the vascular wall (endothelial and smooth muscle cells) and on the 
other side by the glia limitans. Glial endfeet processes almost completely cover the PVS of the larger 
vessels. The glia limitans of the arterial PVS is attached to the pia matter that extends from the SAS 
into the parenchyma. The inset shows the section of the arterial PVS retained for the axisymmetric 
computational model domain. 
 
  
53 
 
The model domain is treated as a CSF‐filled porous medium. The domain outer boundary, bordered 
by the glia limitans, is considered stationary. The inner PVS boundary, bordered by the arterial wall, 
deforms transiently with the passage of pulse waves. The arterial wall motion is derived by 
normalizing the arterial distension wave function from Fujikura et al. [78] with respect to the 
diameter of the considered cortical arteriole and applied to the inner boundary of the model domain 
(Figure 3.3d). To characterize the sensitivity of our findings to the shape of the pulse wave, an 
alternative, asymmetric motion is derived from this first one by only considering the positive 
boundary displacements (Figure 3.3e), thereby providing the most favorable condition for pulse 
wave‐induced net flow in the PVS. The hydraulic resistance of the glia limitans layer is three to four 
orders of magnitude higher than that of the PVS [76]. Accordingly, the outer boundary of the 
axisymmetric domain is considered impermeable. Zero slip and zero solute flux are imposed on both 
the inner and outer boundaries. Zero velocity gradient, constant zero pressure and constant solute 
concentration are imposed at the axial boundaries. 
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Figure 3.3: Fluid motion induced by vascular pulsation in a representative segment of arterial PVS of 
150 µm length and 10 µm width. (a) Illustration of instantaneous flow field in the segment at the 
beginning of the pulsation cycle as shown in panel d. Depicted are streamlines and velocity vectors 
color coded according to velocity magnitude. While the highest speed shown in this figure is 120 
µm/s, the maximum value reached throughout the cycle is 276 µm/s. (b) Flow rate induced by 
physiologic arterial pulsation measured at plane Q indicated in panel a. While instantaneous flow 
rates of up to 1590	μm  /s are observed, the net flow rate averaged over one cycle is only 
0. 372	μm  /s . (c) Flow rate induced by an artificial, asymmetric distension wave as shown in panel e. 
This wave was derived from the physiologic one shown in panel d by setting all negative 
displacements to zero.  The goal was to obtain the highest possible flow rate without changing the 
wave amplitude, frequency and length. The net flow rate measured at plane Q is 1.179	μm  /s, thus 
still very small. 
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The time‐dependent equations governing fluid motion and solute transport, namely modified Navier‐
Stokes with Darcy’s law for the porous medium, continuity and advection‐diffusion equations, are 
solved numerically using the open source finite volume code OpenFOAM [79]: 
  
  
+ (u ∙∇)u −
 
 
∇ u = −
 
 
∇P −
  
  
u,         (3.1) 
∇ ∙u = 0,                                                               (3.2) 
  
  
= (u ∙∇)C + D∇ C,                                         (3.3) 
where the unknowns u, P and C are fluid velocity, pressure, and solute concentration, respectively. 
The parameters µ and ρ are, respectively,  the dynamic viscosity and density of the cerebrospinal 
fluid, ε and K the porosity and permeability of the paravascular space, and D the diffusion coefficient 
of the respective solute. The parameter values are reported in Table 3.1.  
Equations (3.1) to (3.3) are discretized using an implicit Euler scheme for the temporal derivatives 
and central differencing for the first and second order spatial derivatives. All calculations were 
conducted with a time step size of 5 ·10‐5 s and spatial resolution of 0.25	μ  × 0.5	μ  along the axial 
and radial directions, respectively. Grid and time step independence was confirmed. 
          Dispersion coefficient determination 
We postulate that the effect of arterial pulsation on solute transport in a model domain of length L 
can be approximated by the dispersion equation 
  ( , )
  
=
 
  
   
∗   ( , )
  
 ,                         (3.4) 
where x is the spatial coordinate in axial direction and   
∗ is the dispersion coefficient in a segment of 
length L. This equation is structurally equivalent to the well‐known diffusion equation in one 
dimension [35]. To evaluate how closely the dispersion equation captures transport in the arterial 
PVS, we consider the analytical solution of equation (3.4) in a semi‐infinite domain, 
 ( , )
  ( )
= erfc  
 
    
∗ 
 ,                             (3.5) 
where C 	 is the initial concentration. For a finite domain, this approximation is valid as long as the 
penetration Fourier number for the domain length remains small [80]. The value of   
∗ is determined 
by fitting Equation (3.5) to the results of the axisymmetric simulations at t=10s. Using other time 
points that still fulfill the above Fourier criterion results in the same value of   
∗ (maximum deviation 
of 1%). 
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As shown in Figure 3.4, the dispersion equation captures the transport characteristics very well 
(coefficient of determination: R2>0.99). 
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Figure 3.4: Transport of solutes in the arterial PVS in the presence (green lines and symbols) and 
absence (black lines and symbols) of arterial pulsation. Solutes with diffusion coefficients of 2 · and 
10 · 10    	m   s⁄   are considered (circles and squares, respectively).  Symbols show the 
concentration profiles obtained from the 3D axisymmetric simulations 10 seconds after the 
entrance of solutes from the arterial PVS‐SAS interface at X=0. Lines illustrate the best fit curves 
obtained for the diffusion (continuous black lines) and dispersion (dotted green lines) cases. As 
dispersion effects depend on domain length, dispersion results are reported for a bifurcation‐free 
arteriole segment length spanning 150 µm (lower bound of the shaded area) to 250 µm (upper 
bound). The effect of arterial pulsation can be approximated by the analytical solution of the 
dispersion equation (equation (3.5)) without having to account for pulsation explicitly. 
Corresponding dispersion curves (dotted lines) obtained using dispersion coefficients of 3.5 · and 4.2 
· 10    	m   s⁄  (lower and upper green circles) and 12.7 · and 17.0 · 10    	m   s⁄   (lower and upper 
green squares) accurately reproduce the effect of pulsation (coefficient of determination: R2>0.99). 
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          Model of solute transport from arterial to venous paravascular space 
In the second model, we consider a one‐dimensional representation of the solute transport between 
arterial and venous PVS. Our domain consists of a 250 µm long segment of para‐arterial space, 
associated 1 µm thick segment of glia limitans, 300 µm of cerebral cortical tissue separating the 
artery‐vein pair, and again a 1 µm thick segment of glia limitans and 250 µm of para‐venous space. 
All distances are normalized by the total domain length, where X=0 and 1 correspond to the points 
where the para‐arterial and para‐venous spaces, respectively, are exposed to the subarachnoid space 
(see X‐axes of Figures 3.5 and 3.6).  
Based on the observations that 1) arterial pulsations yield negligible bulk flow in the physiological 
regime (Figure 3.3) and 2) the dispersion equation provides a very good approximation of solute 
transport in the arterial PVS (Figure 3.4), we use equation (3.4) to describe solute transport inside 
our one‐dimensional domain. Across the glia limitans and in the cortical ECS, diffusion dominates due 
to the high hydraulic resistance of the interstitial pathways [35, 76]. In the venous PVS, pulsations 
propagating in axial direction are expected to be small, since arterial pulse waves are damped in the 
capillary bed. Accordingly, we assume that the dispersion coefficient reduces to the effective 
diffusion coefficient of solutes across the glia limitans and in the cortical ECS and para‐venous spaces. 
In the para‐arterial space, we use the dispersion coefficient determined from the axisymmetric 
simulations. 
Large brain metabolites (such as amyloid beta) or tracers (such as Dextran 70) are comparable in size 
to the characteristic width of the ECS and gaps between astrocyte endfeet (inter‐endfeet gaps or IEG) 
[35] through which they have to pass on their way from PVS to ECS. As a consequence, the effective 
diffusion coefficient of these larger solutes in their passage through IEG and ECS is lower than that 
for free diffusion in the same fluid. The relation between effective and free diffusion coefficients is 
given according to Deen et al. [81] by 
 
  
=
 
   
  (1 − θ)(1 − 1.004θ + 0.418θ
  + 0.21θ  − 0.169θ ),                 (3.6) 
where D is the effective diffusion coefficient, D  is the corresponding free diffusion coefficient, θ is 
the size ratio of the solute to the relevant channel or ECS dimension and      is the path tortuosity 
determined for a vanishingly small molecule. This equation is used to determine changes in the 
effective diffusion coefficient of solutes when dimensions of IEG or ECS are altered, e.g. due to the 
effects of AQP4 deletion. The equation for solute transport is solved using finite difference 
discretization in Matlab with a forward Euler time stepping scheme, second order central differences 
for the spatial second derivatives, a time step size of 0.01 s and a spatial resolution of 1 μm. 
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Dirichlet boundary conditions for concentrations are imposed on the proximal arterial and distal 
venous PVS interfaces. The exact anatomical configuration of the venous and arterial PVS is still a 
matter of debate and investigation. While artery‐vein pairs have been depicted to penetrate the 
cortex from the cranial SAS in close proximity to each other[16], they have, in contrast, also been 
suggested to have distinctively different starting and end points, with artery and vein penetrating the 
cortex from different regions of the SAS or only the artery reaching from the SAS into the cortex [13].  
We take into account these two anatomical configurations separately to study three distinct cases of 
solute transport concisely illustrated in the insets of Figure 3.5. Case A represents the second 
configuration with the vein returning to the SAS at a distinctively different location than where the 
artery penetrates the cortex. Consequently, there may be different solute concentrations at the 
arterial PVS inlet and venous PVS outlet. For Cases B and C, the first configuration is used, where the 
SAS entry and exit locations of the artery and vein PVS are next to each other, and inlet and outlet 
solute concentrations are thus assumed to be equal at all times. 
Cases A and B consider the transport of solutes originating in the cisterna magna, e.g. due to tracer 
injection. While the solute concentrations at the arterial and venous PVS‐SAS interface are equal in 
Case B, there are different concentrations in the arterial and venous interfaces in Case A due to the 
mentioned difference in vascular configuration. In both cases, the initial tracer concentration is set to 
0 throughout the domain and to 1 at the arterial PVS‐SAS interface. Concentration at the venous PVS‐
SAS interface is set to 0 and 1 in Cases A and B, respectively.  
Case C considers the transport of solutes originating in the parenchymal interstitial space. To mimic 
interstitial tracer injection, the initial solute concentration is set as a rectangular function with the 
value of 1 in a 50 µm wide section at the center of the considered parenchymal segment and 0 
elsewhere. Given the difference in volume between PVS and SAS, solute concentration in the former 
is assumed to not affect the latter, and the solute concentration is maintained at zero at both arterial 
and venous PVS boundaries.
     Results 
          Impact of arterial pulsation on water dynamics in the PVS 
We interrogated the first model to evaluate whether arterial pulsation may induce bulk flow in the 
PVS. To this end, we prescribed the axially propagating distension wave shown in Figure 3.3d to the 
inner boundary of the model domain, and calculated the resulting fluid flow. A representation of the 
flow field by streamlines and velocity vectors is shown in Figure 3.3a. While rather high 
instantaneous axial flow rates of up to 1590	μm   s⁄  are reached (Figure 3.3b), their temporal average 
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over a cardiac cycle is three orders of magnitude lower. This is because the ratio of axial PVS length 
to the wavelength of the distension wave is very small, approximately 1.5 · 10  . Consequently, the 
arterial wall motion is perceived on a local scale as a uniform radial displacement rather than a 
peristaltic motion driving CSF forward, and the resulting bulk CSF flow rate in the PVS is  
0.372	 μm   s⁄ . This flow rate is insensitive to variations of the arterial pulsation characteristics within 
a reasonable range. A change in the distension wave characteristic shape (to make it more 
asymmetric and thus more likely to produce net flow, Figure 3.3c and Figure 3.3e) only increases the 
bulk flow rate to 1.179	 μm   s⁄ . Even when considering the maximum conceivable domain length of 
500 µm, which corresponds to the total characteristic length of a penetrating arteriole, considering 
the lower bound of the wave propagation velocity (0.1 m /s), the upper bound of the mouse heart 
rate (660 bpm) and high displacement amplitude of 1 µm, we obtain a net bulk flow rate of 3.56 
μm   s⁄ , which is still negligibly small. 
          Solute transport in the arterial PVS 
We used again the first model to compare the speed of solute transport through the arterial PVS by 
pure diffusion, pure advection (bulk water flow) and dispersion. We considered solutes with cerebral 
diffusion coefficients in the range of 2 · 10    to 10 · 10    m  /s, which corresponds to larger brain 
metabolites and to tracers used to study paravascular flow [15, 35].  
Table 3.2 lists the distribution length of these solutes determined by first setting the normalized 
solute concentration to 0 inside the model domain and to 1 at the interface with the SAS, and then 
measuring after 10 seconds the distance at which the solute concentration in the PVS has reached 
50% of the initial SAS value. In the context of pure advection, distribution lengths after 10 seconds 
are independent of tracer size and two orders of magnitude smaller than with diffusion, reflecting 
the slow mean bulk flow reported above. In contrast, dispersion yields distribution lengths that are 
16% to 50% longer than those obtained with diffusion alone. The effect of dispersion is more 
pronounced for larger solutes with smaller diffusion coefficients.  
Figure 3.4 illustrates the concentration profiles of the two tracers (D= 2 ·  and 10 · 10   	m  /s) at 10 
seconds in the context of dispersion and pure diffusion. This figure re‐emphasizes that solutes spread 
farther under the effect of dispersion than with diffusion alone. Equation (3.5) (dashed lines) 
provides an excellent approximation of the model results (symbols; coefficient of determination: 
R2>0.99). The dispersion coefficient obtained through equation (3.5) depends on the solute 
considered, but also on the periodic flow induced by the arterial distension wave. The latter is a 
function of PVS segment length. Calculated dispersion coefficients are given in Table 3.2, and used in 
the second model to extend our study of solute transport to the brain tissue and venous PVS. 
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Figure 3.5: Solute transport in the brain for particles of 14 nm size (Dextran 70) with a diffusion 
coefficient of 6 · 10    	m   s⁄  under three different injection scenarios: (a‐b) Case A, cisternal 
injection with a concentration gradient between arterial and venous PVS interfaces, (c‐d) Case B, 
cisternal injection with no concentration gradient, and (e‐f) Case C, interstitial injection. Left column: 
comparison of the concentration profiles at 30 and 120 mins with dispersion and pure diffusion. 
Dispersion results (colored bands) represent a range of plausible dispersion coefficients as reported 
in Table 3.2. Right column: Time evolution of the solute concentration due to dispersion in the 
arterial PVS (at X=0.3), ECS (X=0.5), and venous PVS (X=0.7). 
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Table 3.2: Dispersion coefficients and distribution lengths of the three solutes considered in the 
study. The dispersion coefficient values are reported for PVS segment lengths, L, of 150 and 250 µm. 
The distribution lengths are determined in the context of pure diffusion, pure advection and 
dispersion by first setting the normalized solute concentration to 0 in the arterial PVS and 1 in the 
SAS, and then measuring after 10 seconds the distance at which the solute concentration in the PVS 
has reached 50% of the initial SAS value. 
Diffusion 
coefficient 
(m   s⁄ ) 
Dispersion coefficient (m   s⁄ ) Distribution length (µm) 
L=150 µm L=250 µm Diffusion Advection 
Dispersion, 
L=150 µm 
Dispersion, 
L=250 µm 
2.10‐12 3.5·10‐12 4.2·10‐12 4 0.24 5.4 6.0 
6.10‐12 8.1·10‐12 10.7·10‐12 7 0.24 8.4 9.3 
10.10‐12 12.7·10‐12 17.0·10‐12 9 0.24 10.4 12.0 
 
          Solute transport from para-arterial to the para-venous space 
We interrogated the second model to assess whether dispersion in the arterial PVS may enhance 
overall cortical solute transport despite the absence of bulk flow. To that end, we investigated two 
different injection scenarios: into the cisterna magna (Cases A and B), and directly into the 
parenchymal interstitium (Case C).  
Dispersion caused by arterial pulsation leads, as expected, to faster solute transport in the para‐
arterial space than pure diffusion (Figure 3.5a). As a result, solutes reach the interface between PVS 
and tissue faster, which in turn enhances solute transport through the glia limitans and ECS. The 
higher resistance of glia limitans and ECS to solute passage breaks the smoothness of the graph at 
the location of the glia limitans. Figure 3.5b shows the corresponding time evolution of the solute 
concentration in the arterial PVS, tissue and venous PVS. The directionality of the solute transport 
from arterial PVS to tissue and then venous PVS is reflected by the time shift between the different 
curves. 
The difference in para‐arterial and para‐venous transport is best seen in Cases B and C (Figure 3.5c‐f), 
where identical concentrations are imposed on the arterial and venous interfaces. When considering 
pure diffusion, the symmetry of the boundary conditions results in symmetric concentration profiles 
(Figure 3.5c and e). For cisternal injection, dispersion results in faster penetration along the arterial 
PVS (Figure 3.5c and d). The slower diffusion in the tissue leads to a large concentration gradient 
between arterial PVS and tissue for the entire simulated period of 120 minutes. In contrast, solute 
concentrations in the venous PVS and tissue remain of the same order (Figure 3.5d). For interstitial 
63 
 
injection, dispersion results in faster solute clearance in the arterial PVS (Figure 3.5e) and longer 
tracer residence times in the venous PVS (Figure 3.5f). 
          Impact of glia limitans morphology on solute transport 
The glia limitans plays a critical role in the system considered. As suggested by in vivo observations in 
AQP4 deficient animals, it may modulate solute transport and fluid fluxes between parenchyma and 
PVS [15]. 
Under normal conditions, the inter‐endfeet gap between adjacent astrocytes allows for the passage 
of solutes of up to 20nm hydraulic diameter, while blocking larger ones (see Figure 3.6a). Amiry‐
Moghaddam et al.[82] and Manley et al.[83] report that AQP4 deletion or depolarization also induce 
changes in astrocyte endfoot morphology, possibly due to changes in the balance of osmotic forces 
in intra‐ and extracellular spaces. Should these morphological changes yield an increase in astrocyte 
endfeet volume or coverage area, they may concurrently reduce IEG width and thereby the 
permeability of the glia limitans. To assess whether such hypothetical changes could yield significant 
changes in the overall rates and patterns of tracer transport, we performed a supplementary set of 
calculations with reduced permeability of the glia limitans corresponding to a 30% reduction of IEG 
width from 20 nm to 14 nm. As shown in Figure 3.6b, such reduction in permeability leads to a 
remarkable reduction of solute transport through the ECS, while transport through PVS stays high. 
This is in line with observations in AQP4 deficient animals [15]. 
  
64 
 
 
Figure 3.6: Spatial and temporal distribution of the solute concentrations in the brain (a) for two 
different particle sizes, 14 and 32nm, respectively, assuming an IEG width of 20nm (b) and for the 
14nm particle under the effect of IEG width reduction from 20 nm to 14 nm. Results represent a 
range of plausible dispersion coefficients as reported in Table 3.2. In both cases, the particles enter 
the arterial PVS from the arterial PVS‐SAS interface. While in the normal glia limitans morphology (a) 
the larger particles (32nm in size) are already trapped by this layer and cannot pass into the 
parenchyma, reduction of IEG width (b) also inhibits passage of the smaller solute. 
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     Discussion 
Cerebral water dynamics cannot be measured in vivo with sufficient resolution to support or 
challenge the hypothesis of cortical paravascular bulk flow. We designed two computational models 
to fill this gap. The first one was created to test whether arterial pulsations, which have been 
suggested as possible driving mechanism for bulk flow, can convey solutes at rates demonstrated by 
tracer studies [15, 18, 21, 84]. The second model was designed to test whether dispersion induced by 
arterial pulsation may be responsible for the observed fast para‐arterial solute transport.  
The possibility of pulsation‐driven bulk flow through the arterial PVS has been investigated before by 
computational [26] and analytical modelling [28]. The analytical solution of Wang et al. [28] yields 
unrealistically high mean PVS velocities on the order of cm/s, and is independent of the distension 
wavelength. In contrast, Bilston and co‐workers came to the conclusion that bulk flow is possible for 
short distension wavelengths of 20 to 300 µm and decreases as the wavelength increases. However, 
they did not extend their study to physiologic wavelengths, which are three to four orders of 
magnitude longer [85]. Our results show that under physiologic conditions, arterial pulsations alone 
are unlikely to produce notable bulk flow. The absence of bulk flow in the PVS does not imply 
absence of substantial local fluid motion. Indeed, our results show that arterial pulsation‐induced 
local fluid motion leads to fast solute transport by dispersion even though there is close to zero 
directed bulk flow. This is in line with observations of reduced solute transport in the PVS after aortic 
occlusion [20] or internal carotid artery ligation [68], which reduce cerebral arterial pulsation and 
may thereby reduce dispersion. 
The hypothesis of paravascular bulk flow directed from the arterial to the venous side has not yet 
been reconciled with reports of solute movement in the opposite direction: Both tracers injected into 
the parenchyma [18, 21] and large endogenous proteins [86] have been shown to spread diffusely 
through the parenchyma and then drain out along the arterial wall towards the SAS. Arterial 
paravascular solute transport by dispersion can account for this behavior: Depending on the origin of 
the solute, fast transport can occur towards (Figure 3.5e) or away (Figure 3.5a, c) from the SAS. Since 
dispersion is caused by arterial wall pulsation, transport is faster in the arterial than in the venous 
PVS. This results in faster tracer penetration along the arterial PVS after cisternal injection (Figure 
3.5d) or faster clearance of the para‐arterial space and longer tracer residence time in the venous 
PVS after interstitial injection (Figure 3.5f), both of which are in line with in vivo observations [15]. 
Another indication for pulsation‐mediated para‐arterial transport is the increased deposition of 
amyloid‐beta in the arterial basement membrane of old brains [86]. As arteries stiffen with age, their 
distension amplitude decreases, thereby reducing dispersion in the arterial PVS and increasing 
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protein residence time, which may lead to increased deposition. The observation that deposition 
occurs on the arterial rather than venous side (where transport is slower to begin with) might be 
explained by higher affinity of amyloid beta to structures in the arterial wall. 
The main pillar of the bulk flow hypothesis is that in mice lacking AQP4, tracer transport in the ECS is 
substantially reduced compared to their wild type counterparts. However, the corresponding 
experiments also show that transport in the PVS is affected much less [15]. If there is bulk flow from 
the para‐arterial space through the ECS into the venous PVS, the question arises as to how flow in 
one segment of this chain (ECS) can be reduced substantially while flow in another segment (para‐
arterial space) is affected only marginally. Indeed, we have shown previously that reduced flow 
through the ECS necessitates reduced flow in the PVS to be in line with the bulk flow hypothesis [76].  
While the alternative hypothesis of paravascular solute transport by dispersion is consistent with 
observations of limited change in tracer spread in the para‐arterial space in AQP4‐deficient animals, 
it does pose challenges with respect to reduced extracellular transport: under the assumption that 
the deletion of AQP4 has no other effect than increasing trans‐membrane resistance to water flux, 
our model does not predict any reduction in the speed of tracer spread in the ECS because diffusion 
is dominant in that region [35, 45, 76]. 
Since neither the bulk flow nor the dispersion hypothesis can fully account for the transport behavior 
in absence of AQP4, it is necessary to question the premise of no secondary effects caused by the 
deletion of these water channels. As a matter of fact, there are several reports of changes in 
parenchymal diffusion and ECS volume fraction caused by AQP4 deletion [87, 88]. However, these 
studies show increased extracellular diffusion fluxes and ECS volume fraction in animals lacking 
AQP4, conflicting with studies showing markedly reduced rates of tracer penetration into the 
parenchyma [15]. This conflict may be resolved by considering how the corresponding studies were 
carried out: while local ECS diffusion was determined with brain surface photo‐bleaching [87] and 
TMA+ iontophoresis [88], tracer transport was recorded on a larger scale[15], where the passage of 
solutes between ECS and PVS through the glia limitans becomes relevant. 
The relevant structures for such solute transfer are the astrocyte inter‐endfeet gaps. Beyond global 
changes in ECS volume fraction, there are indications that the endfoot morphology may also be 
affected by AQP4 deletion or depolarization [82, 83], possibly due to the changed balance of osmotic 
forces and intra‐/extra‐cellular volume regulation [89]. These morphological changes may reduce the 
permeability of the glia limitans. The remarkable reduction of ECS solute transport shown in Figure 
3.6 indicates that reasonable morphological changes may limit the transport of small solutes past the 
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glia limitans, just as this structure limits the transport of larger solutes such as FITC‐d2000 under 
normal conditions [15]. 
As any model, the two computational representations used in this study have their limitations. First 
and foremost, we have simplified the cerebral anatomy substantially to three dimensional 
axisymmetric and one dimensional representations, respectively, and considered the PVS as a 
homogenous porous medium. It is principally possible that anisotropies in the PVS may act as one‐
way valves, enabling bulk flow together with arterial pulsation. However, such valves, while 
introduced as a hypothetical concept [27], have not been found to date. Furthermore, the still 
debated matter of the venous drainage site limits the definition of exact boundary conditions. To 
address that difficulty, we characterized solute transport under two extreme scenarios where the 
solute concentration on the distal venous PVS interface is either null or equal to the proximal arterial 
one.  
Next to anatomical approximations, the issue of uncertain parameters is a recurring challenge in 
biophysical modeling. We have dealt with it by performing sensitivity analyses to ensure that the 
conclusions of our study hold within a reasonable parameter range. In particular, the reported 
dispersion coefficients are independent of the PVS hydraulic conductivity, but depend on 
instantaneous flow rates and thereby on PVS segment geometry as well as wave characteristics. 
Importantly, dispersion increases with increasing segment length. We have accounted for this by 
reporting results for a range of bifurcation free segment lengths of 150‐250 µm. While there are both 
shorter and longer segments in the mouse cerebral cortex, their average length in the diameter 
range considered here is 234 μm. We chose the upper value of the segment length range 
purposefully close to this average in order not to overstate the dispersion effect on solute transport 
in the PVS.  
 While very limited data exist on the exact pulse waveform in mouse cortical arterioles, our 
sensitivity analysis indicates that even an extreme asymmetric arterial distension waveform does not 
produce notable bulk flow. Other waveforms not caused by arterial pulse wave propagation but due 
to, for example, local cyclic vascular contraction could principally cause bulk flow [90], provided that 
their wavelengths are orders of magnitude smaller than that of the arterial pulse wave [26]. 
Otherwise, they would simply increase dispersion. No such waves have been identified to date.  
Finally, the modeled effects of possible glia limitans permeability reduction due to AQP4 knock‐out 
need to be viewed as exploratory until corresponding changes to astrocyte endfeet have been shown 
conclusively in vivo. In general, a better characterization of differences in paravascular, interstitial, 
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intracellular and cerebrospinal fluid pathways between wild type and AQP4 deficient mice is 
necessary to correctly interpret the results of tracer studies.  
In summary, we have shown that arterial pulsations may lead to fast transport along the arterial PVS 
due to dispersion, but not due to bulk flow. This may reconcile a number of apparently conflicting 
experimental observations, notably transport in opposite directions in the PVS, i.e. either from the 
SAS to the parenchyma or the reverse, and faster transport in the arterial PVS compared to the 
venous one, which the net water flow assumption could not. While the existence of dispersion does 
not exclude the possibility of bulk flow, the latter would require a yet unidentified driving force as 
well as substantial intracellular flow through astrocyte networks [76]. Our study shows that arterial 
pulsation is unlikely to function as that driving force. 
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Chapter 4 Barrier dysfunction or drainage reduction: Differentiating causes 
of CSF protein increase? 
This chapter has been submitted in the form of a manuscript to the journal of Fluids and Barriers of 
the CNS 
     
    Abstract 
Cerebrospinal fluid (CSF) protein analysis is an important element in the diagnostic chain for various 
central nervous system (CNS) pathologies. Among multiple existing approaches to interpreting 
measured protein levels, the Reiber diagram is particularly robust with respect to physiological inter‐
individual variability, as it uses multiple subject‐specific anchoring values. Beyond the reliable 
identification of abnormal protein levels, the Reiber diagram has the potential to elucidate their 
pathophysiological origin. In particular, both reduction of CSF drainage from the cranio‐spinal space 
as well as dysfunction of the blood‐CNS barriers have been suggested as possible causes of increased 
concentration of blood‐derived proteins. However, there is disagreement on which of the two is the 
true cause. Here we show that high levels of albumin identified in the Reiber diagram are likely to 
originate from a barrier dysfunction rather than from a reduction in CSF drainage. 
 
Keywords 
Computational modeling, cerebrospinal fluid flow, barrier dysfunction, inflammatory diseases, 
immunoglobulin G, albumin 
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Introduction 
Despite continued advances in non‐invasive medical imaging, cerebrospinal fluid (CSF) analysis in 
general and CSF protein analysis in particular have remained important tools for the diagnosis of 
various disorders of the central nervous system (CNS) [91]. Yet while it is accepted that abnormal 
changes in CSF protein content are indicative of pathological conditions, the reasons leading to the 
measured protein concentrations are often a matter of debate [92]. 
While some proteins found in the CSF are synthesized within the CNS (choroid plexus, brain and 
spine) or the meninges, most of them originate in the blood serum under normal conditions [92‐94]. 
They pass through blood‐CNS barriers (either the blood‐brain barrier, BBB, or blood‐CSF barrier, 
BCSFB) into CNS fluids [95]. Equilibrium between the rate‐limited influx of serum derived proteins 
through these barriers and their efflux with CSF drainage determines the protein content of the CSF 
[96]. Changes in the concentrations of these proteins may thus reflect alterations in either 1) serum 
protein levels, 2) intrathecal protein synthesis [97], 3) barrier properties [98], or 4) CSF dynamics and 
drainage [92]. 
Since protein levels in the CSF show normal fluctuations as serum protein concentrations change, 
and since there are inter‐individual variations, it is helpful to use relative values for diagnostic 
purposes. The Reiber diagram constitutes a standardized approach to assessing such values. Should, 
for example, the immunoglobulin G (IgG) concentration in a patient’s CSF sample be analyzed, its 
relative value with respect to serum IgG concentration (IgG quotient) is compared to the 
corresponding relative concentration of albumin (albumin quotient). Since albumin is not synthesized 
in the mature CNS [92], a higher than expected IgG quotient for the given albumin quotient is seen as 
evidence for intrathecal synthesis of IgG and thus for an inflammatory process in the CNS. When 
there is no intrathecal immunoglobulin synthesis, Reiber noted a hyperbolic relationship between 
immunoglobulin and albumin quotients as shown in Figure 4.1, and stated that the albumin quotient 
should remain below 0.01 for normal subjects [92]. He further defined upper and lower bounds for 
the relationship between the two quotients, both of which also follow a hyperbolic function, and 
noted that the relative spread of these bounds, as quantified by a population variation coefficient, 
remains constant over the entire range of investigated albumin levels (Figure 4.1b).      
Of the four possible causes for changes in CSF protein concentration listed above, the Reiber diagram 
corrects for variations in serum protein levels and identifies intrathecal protein synthesis (see Figure 
4.1a). However, it cannot distinguish between changes in CNS barrier properties and changes in CSF 
dynamics and drainage, both of which have been hypothesized as possible causes for abnormal 
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albumin quotients [92, 98, 99]. In this study, we have employed a set of computational tools to test 
these two competing hypotheses.  
To this end, we have analysed how changes in barrier function, CSF drainage rates and pulsatility 
translate to changes of albumin and IgG quotients in the Reiber diagram, where IgG was chosen from 
the family of immunoglobulins arbitrarily as a common biomarker for inflammatory neurological 
disorders [100]. Our models reproduce the empirical mathematical relationship between the two 
quotients given by Reiber, quantify the effect of CSF pulsation on protein distribution and show that 
barrier dysfunction rather than decreased cerebrospinal fluid drainage is the likely cause of 
abnormally high albumin values in the Reiber diagram. 
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Figure 4.1: Variation of the Immunoglobulin G quotient with that of albumin as depicted in Reiber 
diagrams. Empirically established relationship between the concentration of IgG in CSF relative to its 
concentration in blood serum (IgG quotient, QIgG) and the correspondingly defined albumin quotient 
(QAl). Panel (b) depicts the normal range of albumin quotients, corresponding to the area in panel (a) 
marked with the black square. Reiber demonstrated that the average quotient variation (black line) 
and upper and lower bounds (green dashed lines) follow the hyperbolic function 
     =
 
 
    
  +    −   [32]. He also showed that the population variation coefficient (CV), defined 
for a given albumin quotient as    =
∆    
 . ∙          	               	      
, remains constant over the 
entire range of investigated albumin quotients. QIgG values above the upper bound are indicative of a 
blood‐CNS barrier dysfunction. 
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    Methods 
We designed two computational models (Figure 4.2) to investigate the mechanisms governing 
protein distribution in the spinal CSF and underlying reasons for pathological changes in protein 
levels. With a one‐dimensional model (presented second), we evaluate the distribution of albumin 
and IgG in the spinal CSF, accounting for the protein transport rate across blood‐CNS barriers, CSF 
dynamics (including both dispersion induced by CSF pulsations and advection by mean CSF flow) and 
CSF drainage from the cranio‐spinal space. We also study the impact of pathological changes in 
barrier permeability, CSF dynamics and drainage on these distributions. The dispersion coefficients 
used in this one‐dimensional model to account for CSF pulsations are determined a priori by 
computing the axisymmetric three‐dimensional CSF dynamics and solute transport in a 
representative segment of the spinal canal.  
          Three-dimensional model of protein dispersion induced by CSF pulsation 
Dispersion as the combined effect of diffusion and advection by pulsatile fluid motion with zero net 
flow is the governing mechanism for the faster transport of solutes in the CSF compared to pure 
diffusion [29, 30, 40, 101]. To determine dispersion coefficients of albumin and IgG along the spine, 
we first solve the axisymmetric three‐dimensional Navier‐Stokes equations and associated advection‐
diffusion equation for protein transport in a segment of the spinal canal. 
Model characteristics: The geometry of the spinal canal is idealized as an axisymmetric annular pipe 
(Figure 4.3c) with dimensions based on statistical geometrical values reported in the literature [102, 
103]. The thickness of the spinal subarachnoid space varies from cervical region to lumbar space 
within the range of 3.5‐4.5mm [104]. We have used the mean measured value for this thickness in 
the model, 4mm [104]. The segment length is chosen to be long enough to avoid the influence of 
boundary conditions on protein transport rates. All geometrical parameters used are reported in 
Table 4.1.  
The model domain is treated as porous, with permeability and porosity metrics according to 
literature values for the subarachnoid space [105]. A velocity (flow) boundary condition derived from 
MRI measurements of spinal CSF [106] is imposed at the inlet boundary (proximal site), while a 
constant pressure boundary condition is imposed at the outlet (distal site). Both the inner and outer 
boundaries of the spinal canal are treated as impermeable walls with zero slip and zero solute flux 
conditions. Constant solute concentration is imposed at the axial boundaries. 
Solution methodology: The time‐dependent equations governing fluid motion and solute transport, 
namely modified Navier‐Stokes with Darcy’s law for the porous medium, continuity and advection‐
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diffusion equations, are solved numerically using the open source finite volume code OpenFOAM 
[79]: 
 
  
  
+ (u ∙∇)u −
 
 
∇ u = −
 
ρ
∇P −
με
 ρ
u,        (4.1) 
 ∇ ∙u = 0,                                                                 (4.2) 
 
  
  
= (u ∙∇)C + D∇ C,                                          (4.3) 
where the unknowns u, P and C are, respectively, the fluid velocity, pressure, and protein 
concentration. The parameters µ and ρ are the dynamic viscosity and density of the cerebrospinal 
fluid, respectively, ε and K the porosity and permeability of the spinal canal, and D the diffusion 
coefficient of the respective protein. The permeability of the spinal subarachnoid space is derived 
using the solution presented by Gupta et al. [107]. The parameter values are reported in Table 4.1. 
Equations (4.1) to (4.3) are discretized using an implicit Euler scheme for the temporal derivatives 
and central differencing for the first and second order spatial derivatives. All calculations are 
conducted with a time step size of 10    and spatial resolution of 100   in both axial and radial 
directions. Grid and time‐step independence were confirmed. 
Evaluation of the dispersion coefficient: The dispersion coefficient may be derived from the above 
three‐dimensional model by fitting the simulated axial concentration with the analytical solution of 
the dispersion equation in a semi‐infinite domain [101]: 
 
 ( , )
  ( )
= erfc  
 
    
∗ 
 ,                              (4.4) 
where x is the spatial coordinate in axial direction, t is time, C 	is the initial concentration, and   
∗ is 
the dispersion coefficient in a segment of length L. For a finite domain, this approximation is valid as 
long as the penetration Fourier number for the domain length remains small [80]. The value of   
∗ is 
determined by fitting Equation (4.4) to the results of the axisymmetric simulations at t=8s (10 cycles 
of pulsations). For further details of the dispersion coefficient evaluation, we refer the reader to 
[101]. 
          One dimensional model of protein distribution in the spinal CSF 
Our one‐dimensional domain represents protein transport in the spinal CSF between the lumbar and 
cervical region. The model domain is illustrated in Figure 4.3, panel (a). We solve the one‐
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dimensional advection‐diffusion equation modified to include sink and source terms representing 
protein drainage and influx, respectively, as schematically shown in Figure 4.3, panel (b): 
 
  
  
=
   ∗ 
   
+
   
  
+    −   ,        (4.5) 
where C(x,t) is the CSF protein concentration at time t and in axial location x, and u is the CSF bulk 
flow velocity. D* is the protein dispersion coefficient induced by CSF pulsation obtained from our 
three‐dimensional model. The source term, Si, represents the influx of serum proteins into the CSF, 
while the sink term, So, represents protein efflux due to CSF drainage [108]. The dimensions of the 
domain are reported in Table 4.1. 
Evaluation of the dispersion coefficient D*: The dispersion coefficient depends on both the solute 
considered and the amplitude of the CSF pulsations. The latter has been shown to increase from zero 
in the lumbar space [109] to a maximum of about 10     ⁄  in the cervical region [6]. Accordingly, 
we applied our three‐dimensional model to characterize the dispersion coefficients of albumin and 
IgG for CSF pulsation amplitudes ranging between 0 and 10 mm/s. The corresponding dispersion 
values are reported in results section. Expectedly, dispersion equals to diffusion for the pulsation 
amplitude of zero (i.e. in the lumbar space) and increases for the higher pulsation amplitudes, 
reaching a maximum for 10 mm/s velocity (i.e. in the cervical space). Since there is an almost linear 
relation between the imposed velocity and calculated dispersion coefficient, we consider a linear 
increase of the dispersion coefficient from D*min equal to the pure diffusion coefficient in the lumbar 
space to a value of D*max in the cervical region. 
Evaluation of the source term: In absence of active transporters in the blood vessel wall for albumin 
and immunoglobulins, the only transport mechanism for these larger proteins through the barrier is 
slow paracellular diffusion [110]. Therefore, the source term for the CSF concentration could be 
written as: 
    =    ∙(       −  ),             (4.6) 
where Pb stands for the diffusive permeability of the blood‐CNS barriers for the protein under 
consideration and         is the serum protein concentration. The permeability of the barrier to 
albumin molecules in different regions of the CSF compartments has been measured with radioactive 
studies [111]. However, it is not known how this permeability might change due to barrier opening. 
In order to model such permeability variations in pathological situations, we use the membrane pore 
model described in [96], which was demonstrated to accurately capture barrier permeability for 
different proteins. In this model, permeability depends on the ratio of protein size to pore size: 
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    ∝  1 − (   ⁄ ) 
 
∙[1 − 2.1 ∙(   ⁄ ) + 2.09 ∙(   ⁄ )  − 0.95 ∙(   ⁄ ) ],          (4.7) 
where   and r are protein hydrodynamic radius and pore radius, respectively. These values are 
reported in Table 4.1. Barrier permeability to IgG molecules can be described in the same way. .  
Evaluation of the sink term: Since protein efflux occurs by CSF drainage [108], the protein efflux 
pathways are the same as for CSF [112]. These include the arachnoid granulations mainly expressed 
in the cranial space but to a minor extent also in the spinal subarachnoid space, and outflow paths 
along nerves in both cranial and spinal spaces [113]. Thus, the drainage sink term can be written as 
    =   ∙ ,             (4.8) 
where	  is the CSF drainage rate. The total CSF turn‐over rate has been estimated to 500 ml/day in 
humans [5]. However, the distribution of the corresponding drainage between cranial and spinal 
compartments is not fully known [5], let alone its distribution along the spinal axis. To address this 
issue, we leverage available data on the spatial distribution of albumin concentrations at steady 
state, namely the known relative concentrations of albumin in the cisterns, lumbar and cortical 
subarachnoid spaces, and reported albumin concentration gradients along the spinal subarachnoid 
space.  
At steady state, the average concentration in a given compartment can be derived from Equation 
(4.5) and is established by the balance of the source and sink terms. Equating the source and sink 
terms given in Equations (4.6) and (4.8), we obtain the following expression for the albumin quotient, 
QAl, in a given CSF compartment [96]:  
     =
   
         
,             (4.9) 
where the subscript c represents the CSF compartment for which QAl is known, namely the cisterns, 
cortical or spinal subarachnoid spaces, Pbc stands for the barrier permeability in that compartment 
and    for the mean CSF drainage rate to be determined. The corresponding results are reported in 
Table 4.3. The obtained mean drainage characteristics for the spinal compartment,	                , are then 
employed as baseline for other tested scenarios.  
Having calculated the mean CSF drainage rate for the spinal compartment, we determine its local 
value by making use of reported albumin concentration gradients along the neuraxis. Due to the low 
CSF turnover rate, sequential sampling of CSF through a lumbar puncture allows one to sequentially 
access CSF portions from the lumbar, thoracic and finally cervical subarachnoid spaces. Using this 
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method, a decrease of QAl was observed from the first 0‐3 ml of CSF to the last 27–30 ml of CSF 
obtained by lumbar puncture [114]. Having an opposite gradient in CSF drainage has been 
hypothesized as the most probable mechanism for these changing CSF protein concentrations [96]. 
Accordingly, we assume spinal CSF drainage to increase linearly from zero in the lumbar sac (end of 
lumbar region) to twice                  in the cervical region, thereby ensuring that the average spinal 
drainage matches the above determined value,                 .  
Solution method: Equation (4.5) for solute transport is discretized using finite differences in Matlab 
with a forward Euler time stepping scheme and second order central differences for the spatial 
second derivatives. Neumann boundary conditions of zero flux for concentrations are imposed on 
the proximal end of the cervical region and the distal end of the lumbar space. These zero flux 
boundary conditions are reasonable due to the closed end of the lumbar and the steady‐state 
equilibrium between protein influx and efflux in the lumped compartment of cranial space. The 
equation is solved with a time‐step size of 6s and a spatial resolution of 3.5mm, with confirmed time‐
step and grid independence. 
          The Reiber diagram 
Reiber showed that a hyperbolic function can describe the relationship between albumin and 
immunoglobulin quotients seen in a population of patients without intrathecal production of 
immunoglobulins [32]: 
      =
 
 
    
  +    −  ,            (4.10) 
where a, b and c are parameters appropriately chosen to fit the measured patient values. We use 
this empirical relationship as a reference for the output of the protein distribution.  
Reiber further showed that the population variation coefficient, CV, stays constant as the albumin 
quotient changes. CV is defined as the ratio of the IgG variation to its mean value [32]: 
 C  =
         	               	     
 . ∙          	               	      
,            (4.11) 
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Figure 4.2: Study flow chart. This flow chart describes the application of the two computational 
models developed to test hypothesis about the cause of increased CSF albumin quotients. The 
modeling steps and hypotheses are framed by rectangles and rhombi, respectively, while model 
inputs and outputs are shown without bounding boxes.  
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Figure 4.3: Schematic of the model domains. Panel (a) shows a representation of the cerebrospinal 
fluid compartments. The x and arrow parallel to the spinal cord indicate the anatomic 
correspondence and orientation of the one‐dimensional model. Panel (b) shows protein efflux 
locations in the spine. Blood‐derived proteins pass from blood by diffusion into the CSF space and 
exit it along nerve roots. Panel (c) shows a representation of the three‐dimensional model domain as 
an annular channel. The boundary conditions for this model are shown on the domain surfaces. 
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Table 4.1: Model parameters. 
Parameter Value Reference 
Barrier permeability for albumin Pb [      ⁄ ] 
In the cortical subarachnoid space 29.4 [111] 
In the ventricular space 7.6 [111] 
In the spinal space 4.8 [111] 
CSF compartments volume [  ] 
Ventricular space 30  
Cortical subarachnoid space 90  
Spinal subarachnoid space 30  
Protein and pore size used in membrane pore model for barrier 
permeability [  ] 
Pore radius, r 19.4 [96] 
Albumin hydrodynamic radius,     3.58 [96] 
Immunoglobulin G hydrodynamic radius,      5.34 [96] 
CSF production and drainage rate 
CSF total production and drainage rate, F [      ⁄ ] 500 [5] 
CSF pulsation 
CSF pulsation amplitude in the cervical region [    ⁄ ] 10 [6] 
CSF pulsation amplitude in the lumbar region [    ⁄ ] 0 [109] 
CSF pulsation time period [ ] 0.8 [6] 
CSF physical properties 
Density,   [     ⁄ ] 1000  
Viscosity,   [  .  ] 0.001  
Spinal canal porosity and permeability 
Porosity,   0.99 [107] 
Permeability in the longitudinal direction, Klongitudinal [ 
 ] 1.45∙10   [107] 
Permeability in the radial direction, Kradial [ 
 ] 2.36 ∙10   [107] 
CSF albumin concentrations 
Albumin concentration in the lumbar CSF [     ]⁄  0.363 [111] 
Albumin CSF/blood quotient in the lumbar space 0.002 [114] 
Albumin quotient ratio (lumbar to cisternal) 2 [111] 
Albumin quotient ratio (cortical SAS to cisternal) 3 [111] 
Dimensions 
Spinal cord diameter in the second model [  ] 10 [103, 104] 
Spinal subarachnoid space thickness in the second model, w [  ] 4 [103, 104] 
Spinal segment length in the 3D model domain [  ] 100  
Spine length between cistern and lumbar space [  ] 700  
Protein properties 
Albumin diffusion coefficient, DAl [ 
   ⁄ ] 6 ∙10     
Immunoglobulin G diffusion coefficient, DIgG [ 
   ⁄ ] 2.4 ∙10     
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    Results 
          Transport of the molecules in the spinal canal 
We interrogated the 3D axisymmetric model to evaluate protein transport resulting from pulsatile 
spinal CSF motion. The diffusion coefficients of albumin and IgG in CSF are 6 · 10    and 2.4 · 10    
m  /s, respectively. A peak CSF velocity of 10 mm/s was considered as reference [6]. The resulting 
dispersion coefficients are summarized in Table 4.2. Since the CSF pulsation amplitude reduces along 
the spinal canal towards the lumbar space [109], we also calculated the dispersion coefficient for 
lower velocities. Puy et al. showed that CSF pulsations can change in pathological situations [33], 
demonstrating an up to four fold increase in amplitude. To evaluate the impact of such pathological 
variations on protein distribution, we also calculated dispersion coefficients for accordingly increased 
velocities. We observed an almost linear increase in the dispersion coefficients with increasing 
velocity amplitude. 
Table 4.2: Calculated protein dispersion coefficients.  
Molecule Diffusion coefficient (m  /s) Maximum CSF 
velocity (mm/s) 
Dispersion coefficient (m  /s) 
Immunoglobulin G 2.4 · 10    10 4.0 · 10   
Albumin 6.0 · 10    
2.5 2.8 · 10   
5 2.2 · 10   
10 6.0 · 10   
20 1.3 · 10   
40 2.7 · 10   
 
            
82 
 
          Distribution of albumin and IgG in the spinal CSF: baseline condition 
We first determined the distribution of CSF drainage between cortical and spinal spaces as outlined 
in the Methods section and then calculated albumin and IgG quotients using the one‐dimensional 
model. Drainage distribution and albumin quotients in different regions of the CSF space are 
summarized in Table 4.3. The distribution of albumin and IgG quotients in the spinal canal between 
lumbar and cervical regions is shown in Figure 4.4. 
Table 4.3:  CSF drainage distribution and albumin quotients in different CSF compartments. 
CSF drainage distribution 
Cortical region 82% 
Spinal region 18% 
Albumin quotients in different CSF compartments 
Lumbar spine 0.002 
Cortical SAS 0.003 
Cistern 0.001 
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Figure 4.4: Albumin and IgG quotient distribution in the spinal cerebrospinal fluid. x is the normalized 
location on the rostro‐caudal axis from lumbar (x=0) to cervical space (x=1) as illustrated in Figure 
4.3, panel (a). Quotients are obtained using spinal CSF drainage rates calculated as outlined in the 
Methods section. Permeability of the blood‐CNS barrier to IgG is obtained using equation (4.7). 
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          Impact of CSF pulsation amplitude change on protein distribution 
We employed the 1D model of albumin distribution in conjunction with the dispersion rates obtained 
using the 3D model of protein transport in the spinal space to assess the effect of changes in CSF 
pulsation amplitude. We investigated the effect of a factor of four increase in CSF pulsation 
amplitude observed in chronic hydrocephalus patients [33] and used the corresponding dispersion 
coefficient calculated in the previous section. Figure 4.5 shows the impact of CSF pulsation amplitude 
change on the steady state albumin distribution in the spinal CSF. An increase in CSF velocity 
amplitude results in a more even albumin distribution in the spinal canal, whereas a decrease 
intensifies the concentration gradient. 
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Figure 4.5: Impact of changes in CSF pulsation amplitude on the steady state albumin quotient 
distribution. x is the normalized location on the rostro‐caudal spinal axis from lumbar (x=0) to 
cervical space (x=1) in Figure 4.3, panel (a). The solid black line represents the nominal condition 
with CSF velocity amplitude of 10 mm/s (dispersion coefficient of 6 · 10   	    ⁄ ), the red dashed 
and blue dashed‐dotted lines represent conditions with a factor of four velocity amplitude reduction 
or increase, respectively (dispersion coefficients: 6 · 10   	    ⁄  and 3.6 · 10   	    ⁄  , 
respectively). Higher CSF velocity amplitudes reduce albumin gradients in the spinal cerebrospinal 
fluid space. 
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          Impact of barrier dysfunction and CSF drainage on protein quotients 
We used the 1D model to investigate the effect of changes in blood‐CNS barrier permeability and CSF 
drainage on albumin and IgG quotients in the lumbar cerebrospinal fluid. Figure 4.6 panel (a) shows 
the relationship between IgG and albumin quotients in the cases of barrier permeability change 
(circles) and CSF drainage rate change (solid black line). An albumin quotient of 0.002 is taken as the 
nominal value. Decrease in CSF drainage and increase in barrier permeability lead to increased IgG 
and albumin quotients, and vice versa. The empirical hyperbolic relation between albumin and IgG 
quotients derived by Reiber [92] from measurements in patients’ CSF samples is shown to match well 
with our calculations for barrier permeability change (solid red line).  
Figure 4.6 panel (b) illustrates the effect of change in barrier permeability for three different constant 
CSF drainage rates. The center (dashed) curve corresponds to nominal drainage, while the upper and 
lower solid curves correspond to 30% increased and decreased drainage rates, respectively. All three 
curves are hyperbolic. We used the upper and lower curves to calculate representations of the 
population variation coefficient, obtaining values of 0.48, 0.44 and 0.4 for albumin quotients of 
0.001, 0.002 and 0.003, respectively. Note that the population variation coefficient determined by 
Reiber based on patient data is constant over a range of albumin quotients.  
Figure 4.6 panel (c) illustrates the effect of change in barrier permeability for three different baseline 
IgG permeabilites, reflecting the variation of the barrier permeability to IgG to different extent than 
for albumin as shown by Seyfert et al. [115]. The center (dashed) curve corresponds to nominal 
baseline IgG permeability, while the upper and lower solid curves correspond to 30% increased and 
decreased baseline IgG permeability, respectively. The representation of the population variation 
coefficient is in this case 0.6 for all albumin quotients. 
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Figure 4.6: Relationship between IgG quotient and albumin quotient as commonly shown in the 
Reiber diagram. Panel (a): Blue circles show how isolated changes in barrier permeability shape the 
relation between IgG and albumin quotients, while the black solid line demonstrates the 
corresponding effect of isolated changes in CSF drainage rate. The albumin quotient of 0.002 is taken 
as the nominal value. Decrease in CSF drainage and increase in barrier permeability lead to increased 
IgG and albumin quotients, and vice versa. Quotient variations due to changes in barrier permeability 
are perfectly described by the hyperbolic function (Eq. 10) empirically derived by Reiber (red solid 
line, Rsquare = 1).  In contrast, quotient variations due to changes in CSF drainage follow a linear trend. 
Panel (b) shows quotient variation due to barrier permeability change. The dashed line represents 
nominal CSF drainage conditions, while the upper and lower solid lines are representative of 30% 
increased and decreased CSF drainage rates, respectively. The population variation coefficient for 
albumin quotients of 0.001, 0.002, 0.003 is, respectively, 0.48, 0.44 and 0.4. Panel (c) shows the 
effect of barrier permeability change for three different baseline IgG permeabilities. The dashed line 
represents the nominal IgG permeability and upper and lower solid lines represent 30% increased 
and decreased IgG baseline permeability, respectively. The calculated variation coefficient is constant 
(with a value of 0.6) for all albumin quotients. 
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    Discussion 
The biochemical analysis of the cerebrospinal fluid is an important diagnostic tool for pathologies of 
the CNS. For example, changes in CSF immunoglobulin content can be indicative of inflammatory 
reactions in the brain. To account for inter‐individual and normal intra‐individual variability, it is 
advantageous to assess relative rather than absolute values of protein concentration as done in the 
Reiber diagram. While the Reiber diagram can indicate intrathecal synthesis of proteins, it is debated 
whether higher than normal readings of relative albumin concentrations are indicative of CNS barrier 
dysfunction or reduction in CSF drainage. Here we have employed a set of computational models to 
assess which one of these two changes is the more likely cause of increased albumin concentration in 
CSF relative to that in the blood plasma. 
The Reiber diagram features a hyperbolic relationship between albumin quotient and, for example, 
IgG quotient, where ‘quotient’ refers to the concentration of the respective protein in CSF relative to 
its concentration in blood plasma. Reiber derived this empirical relationship from measurements in a 
large set of patients in which intrathecal synthesis of the protein of interest could be excluded. He 
hypothesized that this non‐linear relationship was caused by inter‐patient variability in CSF drainage 
rates [32]. However, as shown in Figure 4.6, panel (a), our models indicate that variations in the rate 
of CSF drainage would yield a linear relationship between the quotients rather than the 
experimentally determined hyperbolic one. Reiber also calculated the variation coefficient for his 
patient database and found it to be constant for a large range of albumin quotients. Our calculations 
show that the variation coefficient does not stay constant for different baseline CSF drainage values 
(Figure 4.6 panel (b)), indicating that inter‐patient variability in CSF drainage alone may not result in 
the protein quotient relationship observed by Reiber. One should thus not, without further case‐
dependent evidence, attribute abnormally high albumin quotients identified in the Reiber diagram to 
reduced CSF drainage. 
Others have attributed increased albumin quotients to blood‐CNS barrier dysfunction. Indeed, as 
shown in Figure 4.6, panel (a), variation in barrier permeability leads to the expected hyperbolic 
relationship between protein quotients. This is further confirmed by a constant population variation 
coefficient as illustrated in panel (c) for different baseline IgG permeabilities. Consequently, high 
albumin quotients identified in the Reiber diagram may be seen as indicative of a CNS barrier 
dysfunction. 
Our calculations of the distribution of CSF efflux indicate 18% drainage in the spinal compartment 
and 82% drainage in the cranial compartment. This distribution matches well with the measurements 
of Marmarou et al. [116] in cats, where absorption in the spinal space accounted for 16% of the total 
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CSF drainage and the cranial space contributed 84%. Similar results were obtained by Gehlen et al. 
using a lumped parameter model of coupled cardiovascular and CSF dynamics [117]. Albumin 
quotients calculated based on this drainage distribution are within the range of values obtained 
experimentally in healthy subjects [114].  
Seyfert et al. measured albumin and immunoglobulin concentration gradients in the spinal CSF by 
sequential CSF sampling through lumbar puncture. They showed a decreasing protein concentration 
profile from lumbar to cervical space [114]. It was hypothesized that this concentration gradient 
results from the variation of CSF drainage along the spine [96]. Our calculations show that the 
hypothesized drainage gradient along the spinal canal with minimum drainage rate in the lumbar 
space would, indeed, result in a longitudinal concentration gradient for albumin and IgG (Figure 4.4). 
Therefore, our results support the existence of rostro‐caudally decreasing spinal CSF drainage. 
Puy et al. correlated the magnitude of CSF pulsation with protein distribution in different CSF 
compartments [33]. We calculated the dispersion rate of albumin in the spinal CSF for different 
pulsation amplitudes as reported in Table 4.2, and employed these values in our global protein 
distribution model. Increased CSF pulsation diminishes the longitudinal concentration gradient, while 
reduced pulsation intensifies it in the spinal canal (Figure 4.5). These results are in line with the 
measurements of Puy et al. [33]. Therefore, changed CSF dynamics in pathologies such as 
hydrocephalus and Chiari malformation could have an impact on protein distribution in the spinal 
canal.  
The two computational models developed in this study have the following main limitations: First and 
foremost, we have simplified the spinal canal anatomy substantially to a 3D axisymmetric annular 
conduit and a 1D representation, respectively, considering the spinal subarachnoid space as a porous 
medium. Both the macroscopic anatomy as well as the microanatomy of the CSF spaces as defined 
by, e.g., arachnoid trabeculae, could play an important role in fluid and solute dynamics. Neglecting 
the microanatomy can lead to discrepancies between computed and measured metrics of spinal CSF 
dynamics [106]. In our models, the effect of microstructures is approximated by the introduction of 
anisotropic permeability of the porous medium representing the spinal subarachnoid space.  
The second main limitation pertains to the issue of parameter uncertainty. For instance, we have 
considered the overall CSF drainage rate to be equal to the estimated value of CSF production, which 
itself is only known approximatively [5]. We have dealt with parameter uncertainty by performing 
sensitivity analyses, which show that our main conclusions are robust with respect to reasonable 
variations of the model parameters. Concretely, we have shown that the hyperbolic protein quotient 
function in the Reiber diagram that results from variation in barrier permeability does not depend on 
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baseline CSF drainage (Figure 4.6, panel b) or IgG permeability values (Figure 4.6, panel c). We have 
also made sure that the population variation coefficient does not only stay constant for a 30% 
change in IgG baseline permeability (Figure 4.6 panel c), but also for much larger and smaller changes 
(up to 100% change). Finally, we checked that the derived dispersion coefficients do not depend on 
the computational domain length and hydraulic conductivity of the domain. 
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Chapter 5 Conclusion and outlook 
The focus of this doctoral thesis is on the impact of the cerebrospinal fluid dynamics on solutes 
transport and distribution in the central nervous system. The first part of the thesis including 
chapters 2 and 3 was dedicated to micro‐scale solutes transport mechanisms in the cerebral 
paravascular and extracellular pathways. The second part (chapter 4) discusses the macro‐scale 
transport of proteins and their distribution in the spinal subarachnoid space.  
As indicated in chapter 2, diffusion is the main mode of solutes transport in the parenchymal 
extracellular pathways. With the assumption of bulk flow between arterial and venous paravascular 
spaces, astrocyte networks could facilitate water flow that enhance metabolite clearance through a 
parallel, extracellular route. Reduced solutes clearance in animals lacking AQP4 may be explained by 
diminished bulk flow caused by inhibition of the interconnection between the astrocyte networks 
and the extracellular route. However, the question remains as to whether there exists any bulk flow 
in the brain parenchyma and paravascular network or not. The potential CSF bulk flow in the 
paravascular space requires the presence of a driving force that has not been determined to date, 
but for which arterial pulsation has been suggested as the origin. In chapter 3, we have shown that 
arterial pulsations may lead to fast solutes transport along the arterial PVS due to dispersion, but not 
due to bulk flow. Dispersion may also reconcile a number of apparently conflicting experimental 
observations, notably transport in opposite directions in the PVS, i.e. either from the SAS to the 
parenchyma or the reverse, and faster transport in the arterial PVS compared to the venous one, 
which the net CSF flow assumption could not. While the existence of dispersion does not exclude the 
possibility of bulk flow, the latter would require a yet unidentified driving force as well as substantial 
intracellular flow through astrocyte networks as shown in chapter 2.  
In chapter 4, we extended our study to investigate the importance of the macro‐scale cerebrospinal 
fluid dynamics for solutes transport and distribution in the spinal subarachnoid space. We showed 
that CSF protein levels depend on the characteristics of the blood‐CNS barrier, i.e. its permeability 
and structure, but also rely on the dynamics of the cerebrospinal fluid in the vicinity of the barrier. 
Pathological changes including barrier dysfunction and CSF flow drainage change might result in the 
variation of proteins level. With the use of computational models, we also demonstrated that barrier 
dysfunction could explain the protein variation characteristics observed in the Reiber diagram.  
This thesis underscores the capabilities of computational modeling to investigate the physiological 
aspects of water and solutes transport in the brain. The limitations of the state of the art 
experimental techniques sometimes hinder concrete conclusions about water and solutes transport 
pathways. One good example for such complication in the experiments interpretation is paravascular 
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solute transport. For long time in spite of pool of experimental observations, scientists have been 
questioning the direction and type of transport in the cerebral paravascular space. Part of this 
complication raises from the fact that single water molecules could not be traced experimentally. 
Thus, water movement is only inferred from the larger tracer molecules movement. As we showed in 
chapter 3, fast tracer movement has nothing to show about the bulk water dynamics as mostly 
interpreted from the experiments. This example and other parts of this thesis indicate that 
computational modelling could play an important role in filtering biological hypotheses and assess 
their feasibility with biophysical rules.  
    Outlook 
There are still lots of aspects of our subject of interest “water and solutes dynamics in the central 
nervous system” which could potentially attract extensive research and scientific work. In spite of 
massive work done to understand the cerebral transport mechanisms which is partly referenced in 
this thesis, there is still lack of experimental data which hampers improving the computational 
models. In this section, I list some which may warrant further research to confirm or infirm 
hypotheses made herein and help advance models of water and solutes transport in the central 
nervous system.   
Our developed computational models as any other model have their limitations which are clearly 
stated in each chapter. Simplification of the anatomy is a common aspect of biological models which 
is also employed in this study for astrocyte cells, extracellular pathways, paravascular spaces and also 
spinal subarachnoid space. Such simplifications are done due to lack of thorough anatomical 
knowledge of several features such as sophisticated geometry of astrocytes, three dimensional 
reconstruction of paravascular spaces and complex micro anatomy of arachnoid trabeculae in the 
spinal subarachnoid space. To address this difficulty we conducted throough sensitivity analyses to 
ensure that the conclusions derived in this thesis do not depend on the choice of model parameters 
and hold true for a reasonable variation of the parameters around the chosen value.  However, there 
is this hope that with the progress in imaging techniques and resolution, it will be possible to resolve 
the complicated anatomical features such as the three‐dimensional morphology of the cell and its 
processes. This progress would allow for the analysis of transport mechanisms in correct biological 
morphologies which might add to our knowledge about central nervous system and its functioning. 
The available experimental data for micro‐scale or cellular level transport pathways in the brain is 
very rare and mostly qualitative. Our numerical models indicate that cellular transport could be of 
high importance for the water and metabolites transport in the brain tissue. However, what happens 
to water and solutes moving through the intracellular pathways is not experimentally clear. 
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Concerning the new evidences raised in the literature on the significance of the molecular and 
cellular transport pathways, it seems crucial for the relevant scientific community to move in this 
direction and look at these aspects experimentally in more details. For instance, water and solutes 
transport in cellular networks in the brain as discussed for the astrocytes network in chapter 2 could 
be a potentially high impact research for the successors.  
In addition to the having more detailed information on the morphology of biological structures, 
transport pathways and cellular networks in the central nervous system, a better understanding of 
the brain mechanics is also crucial for numerical modelling of the brain. As we demonstrated in 
chapter 4, brain tissue motion could affect brain water and solutes transport largely. However, brain 
motion in micro‐scales is not thoroughly investigated. For instance, tissue motion in vicinity of the 
paravascular space in the glial endfeet layer could play an important role for solutes transport in the 
PVS. Since we did not have access to such data, we assumed no motion in this region and reported 
the rate of solutes dispersion only under arterial pulsations neglecting tissue pulsations in the 
perivascular region which should be a low extreme value for the dispersion rate.  
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